Gryphon Digital Mining (GRYP) POS AM 7 Jan 21 Prospectus update (post-effective amendment) Financial data

Document and Entity Information

Document and Entity Information	3 Months Ended
	Sep. 30, 2020
Document and Entity Information [Abstract]
Entity Registrant Name	Akerna Corp.
Entity Central Index Key	0001755953
Amendment Flag	true
Amendment Description	Akerna Corp. (“Akerna”, the “registrant”, “we” or “our”) hereby filed this Post-Effective Amendment No. 1 to its Registration Statement on Form S-1 (No. 333-239783) to update the prospectus contained therein to (i) reflect that 627,225 shares of common stock were previously issued upon conversion of Exchangeable Shares leaving 2,667,349 shares of common stock issuable upon conversion, (ii) add its financial statements for the fiscal year ended June 30, 2020 and for the three-month period ended September 30, 2020, (iii) update the related management’s discussion and analysis of financial condition and results of operations (iv) to reflect recent material events and (v) update unaudited pro forma financial information. Pursuant to Rule 416, this Registration Statement also covers additional securities that may be offered as a result of anti-dilution provisions regarding stock splits, stock dividends, or similar transactions relating to the shares of common stock issuable upon exchange of redeemable preferred shares covered by this registration statement. The Registrant previously paid a registration fee of $3,369.77 in connection with the filing of the initial registration statement on Form S-1 (No. 333-239783) filed with the Securities and Exchange Commission on July 9, 2020, to register the 3,294,574 shares of common stock. We hereby amend this registration statement on such date or dates as may be necessary to delay our effective date until we will file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until this Registration Statement will become effective on such date as the Securities and Exchange Commission, in accordance with Section 8(a) may determine.
Document Type	POS AM
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Sep. 30, 2020
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Incorporation, State or Country Code	DE

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Sep. 30, 2020	Jun. 30, 2020	Jun. 30, 2019
Current assets:
Cash	$ 14,257,858	$ 24,155,828	$ 21,867,289
Restricted cash	500,000	500,000	500,000
Accounts receivable, net	2,799,225	1,861,534	1,257,274
Prepaid expenses and other current assets	1,475,613	1,215,341	577,674
Total current assets	19,032,696	27,732,703	24,202,237
Non-current assets:
Fixed assets, net	1,395,690	131,095
Investment, net	244,774	246,308
Capitalized software, net	3,389,646	2,629,304
Intangible assets, net	10,730,021	7,493,975
Goodwill	46,500,030	20,254,309
Other non-current assets	41,925	41,925
Total Assets	81,334,782	58,529,619	24,202,237
Current liabilities
Accounts payable and accrued liabilities	5,998,001	4,861,928	1,818,116
Contingent consideration payable	817,000	389,000
Deferred revenue	1,170,625	368,685	624,387
Current portion of long-term debt	10,146,001	6,135,364
Total current liabilities	18,131,627	11,754,977	2,442,503
Long-term debt, less current portion	5,481,599	10,200,236
Total liabilities	23,613,226	21,955,213	2,442,503
Commitments and contingencies (Note 6)
Equity:
Preferred stock, par value $0.0001; 4,999,999 shares authorized, none are issued and outstanding at September 30, 2020 and 5,000,000 shares authorized and none are issued and outstanding at June 30, 2020
Common stock, par value $0.0001; 75,000,000 shares authorized, 14,685,932 issued and outstanding at September 30, 2020, and 13,258,707 shares issued and outstanding at June 30, 2020	1,464	1,321	1,059
Additional paid-in capital	83,164,840	72,906,924	47,325,421
Accumulated other comprehensive (loss) income	(7,000)	63,000
Accumulated deficit	(45,842,967)	(41,101,091)	(25,566,746)
Total stockholders' equity	57,721,556	31,870,154	21,759,734
Noncontrolling interests in consolidated subsidiary		4,704,252
Total equity	57,721,556	36,574,406	21,759,734
Total liabilities and equity	81,334,782	$ 58,529,619	$ 24,202,237
Special Voting Preferred Stock
Equity:
Preferred stock, par value $0.0001; 4,999,999 shares authorized, none are issued and outstanding at September 30, 2020 and 5,000,000 shares authorized and none are issued and outstanding at June 30, 2020	$ 20,405,219

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2020	Jun. 30, 2020	Jun. 30, 2019
Preferred stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	4,999,999	5,000,000	5,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	75,000,000	75,000,000	75,000,000
Common stock, shares issued	14,685,932	13,258,707	10,589,746
Common stock, shares outstanding	14,685,932	13,258,707	10,589,746
Special Voting Preferred Stock
Preferred stock, par value	$ 0.0001
Preferred stock, shares authorized	1
Preferred stock, shares issued	1
Preferred stock, shares outstanding	1
Preferred stock, liquidation preference per share		$ 1

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	3 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Revenues
Software	$ 3,154,442	$ 2,254,480	$ 9,976,580	$ 8,256,492
Consulting	331,080	831,363	2,379,947	2,307,129
Other	228,482	107,047	216,749	259,496
Total revenues	3,714,004	3,192,890	12,573,276	10,823,117
Cost of revenues	1,739,937	1,379,701	6,209,724	4,633,844
Gross profit	1,974,067	1,813,189	6,363,552	6,189,273
Operating expenses
Product development	1,758,826	610,902	3,206,310	5,565,097
Sales and marketing	2,097,502	1,841,514	7,792,480	7,498,114
General and administrative	2,470,187	1,742,301	11,320,715	5,638,408
Depreciation and amortization	1,171,022	17,899	1,315,898
Total operating expenses	7,497,537	4,212,616	23,635,403	18,701,619
Loss from operations	(5,523,470)	(2,399,427)	(17,271,851)	(12,512,346)
Other income (expense)
Interest (expense), net	(3,687)	73,382	156,678	91,239
Change in fair value of Convertible Notes	778,000		766,000
Other		(287)	(254)	17,892
Total other income (expense)	774,313	73,095	922,424	109,131
Net loss before income tax expense	(4,749,157)	(2,326,332)	(16,349,427)	(12,403,215)
Income tax expense			(30,985)
Equity in losses of investee	(1,534)		(3,692)
Net loss	(4,750,691)	(2,326,332)	(16,384,104)	(12,403,215)
Net loss attributable to noncontrolling interest in consolidated subsidiary	8,815		849,759
Net loss attributable to Akerna shareholders	$ (4,741,876)	$ (2,326,332)	$ (15,534,345)	$ (12,403,215)
Basic and diluted weighted average common stock outstanding	14,058,412	10,879,112	11,860,212	6,045,382
Basic and diluted net loss per common share	$ (0.34)	$ (0.21)	$ (1.31)	$ (2.05)

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($)	3 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Statement of Comprehensive Income [Abstract]
Net loss	$ (4,750,691)	$ (2,326,332)	$ (16,384,104)	$ (12,403,215)
Other comprehensive (loss) income:
Unrealized loss on Convertible Notes	(70,000)		63,000
Comprehensive loss	(4,820,691)	(2,326,332)	(16,321,104)	(12,403,215)
Comprehensive loss attributable to the noncontrolling interest	8,815		849,759
Comprehensive loss attributable to Akerna shareholders	$ (4,811,876)	$ (2,326,332)	$ (15,471,345)	$ (12,403,215)

Consolidated Statements of Chan

Consolidated Statements of Changes in Equity - USD ($)	Special Voting Preferred Stock	Common	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Akerna Shareholders’ Equity	Noncontrolling Interest in Consolidated Subsidiary	Total
Balance at Jun. 30, 2018		$ 492	$ 14,563,102		$ (13,163,531)	$ 1,400,063		$ 1,400,063
Balance, shares at Jun. 30, 2018		4,922,650
Issuance of common stock		$ 110	9,999,890			10,000,000		10,000,000
Issuance of common stock, shares		1,099,376
Issuance of common stock in connection with reverse merger		$ 388	18,878,387			18,878,775		18,878,775
Issuance of common stock in connection with reverse merger, shares		3,880,282
Issuance of common stock for compensation in connection with reverse merger		$ 50	3,393,231			3,393,281		3,393,281
Issuance of common stock for compensation in connection with reverse merger, shares		498,073
Stock-based compensation amortization			490,830			490,830		490,830
Common stock issued upon cashless exercise of options		$ 19	(19)
Common stock issued upon cashless exercise of options, shares		189,365
Net loss					(12,403,215)	(12,403,215)		(12,403,215)
Balance at Jun. 30, 2019		$ 1,059	47,325,421		(25,566,746)	21,759,734		21,759,734
Balance, shares at Jun. 30, 2019		10,589,746
Amortization of stock-based compensation			161,165			161,165		161,165
Cash received in connection with exercise of warrants		$ 37	4,242,417			4,242,454
Cash received in connection with exercise of warrants, shares		368,910
Net loss					(2,326,332)	(2,326,332)		(2,326,332)
Balance at Sep. 30, 2019		$ 1,096	51,729,003		(27,893,078)	23,837,021		23,837,021
Balance, shares at Sep. 30, 2019		10,958,656
Balance at Jun. 30, 2019		$ 1,059	47,325,421		(25,566,746)	21,759,734		21,759,734
Balance, shares at Jun. 30, 2019		10,589,746
Stock-based compensation amortization			1,253,234			1,253,234		1,253,234
Common stock issued upon warrant exercise		$ 37	4,247,028			4,247,065		4,247,065
Common stock issued upon warrant exercise, shares		369,311
Common stock issued in business combinations		$ 230	20,081,236			20,081,466		20,081,466
Common stock issued in business combinations, shares		2,299,650
Noncontrolling interest in acquired subsidiary							5,554,011	5,554,011
Forfeitures of restricted shares		$ (5)	5
Forfeitures of restricted shares, shares		(54,901)
Change in fair value of Convertible Notes				63,000		63,000		63,000
Net loss					(15,534,345)	(15,534,345)	(849,759)	(16,384,104)
Balance at Jun. 30, 2020		$ 1,321	72,906,924	63,000	(41,101,091)	31,870,154	4,704,252	31,870,154
Balance, shares at Jun. 30, 2020		13,203,806
Special voting preferred stock issued in business combination	25,203,490					25,203,490		25,203,490
Conversion of Exchangeable Shares to common stock	(4,798,271)	$ 63	4,798,208
Conversion of Exchangeable Shares to common stock, shares		627,225
Acquisition of noncontrolling interest		$ 80	4,695,357			4,695,437	(4,695,437)
Acquisition of noncontrolling interest, shares		800,000
Amortization of stock-based compensation			764,351			764,351		764,351
Restricted stock unit vesting
Restricted stock unit vesting, shares		3,025
Issuance of common stock in connection with reverse merger								25,200,000
Change in fair value of Convertible Notes				(70,000)		(70,000)		(70,000)
Net loss					(4,741,876)	(4,741,876)	(8,815)	(4,750,691)
Balance at Sep. 30, 2020	$ 20,405,219	$ 1,464	$ 83,164,840	$ (7,000)	$ (45,842,967)	$ 57,721,556		$ 57,721,556
Balance, shares at Sep. 30, 2020		14,634,056

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	3 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Cash flows from operating activities
Net loss	$ (4,750,691)	$ (2,326,332)	$ (16,384,104)	$ (12,403,215)
Adjustment to reconcile net loss to net cash used in operating activities:
Bad debt expense	12,450	252,809	1,094,507	345,941
Stock-based compensation expense	681,419	161,165	1,166,130	3,884,111
Depreciation and amortization	1,171,022	17,899	1,315,898
Foreign currency loss	4,901
Equity in losses of investment	1,534		3,692
Debt issuance costs classified as financing			1,177,390
Change in fair value of convertible notes	(778,000)		(766,000)
Change in fair value of contingent consideration	(389,000)		(998,000)
Changes in operating assets and liabilities:
Accounts receivable	(9,298)	(1,508,217)	(1,621,262)	(1,572,889)
Prepaid expenses and other current assets	(74,023)	(292,272)	(592,807)	(351,144)
Other assets			(58,925)
Accounts payable and accrued liabilities	(296,802)	274,566	1,602,751	893,845
Deferred revenue	245,329	278,208	(286,922)	154,756
Net cash used in operating activities	(4,181,159)	(3,142,174)	(14,347,652)	(9,048,595)
Cash flows from investing activities
Developed software additions	(624,863)	(519,739)	(3,102,728)
Furniture, fixtures, and equipment additions	(12,203)		(156,636)
Cash paid for business combinations, net of cash acquired	(5,067,740)		(88,720)
Investment in equity method investee			(250,000)
Cash received in connection with the reverse merger				18,843,483
Net cash provided by investing activities	(5,704,806)	(519,739)	(3,598,084)	18,843,483
Cash flows from financing activities
Cash paid for deferred stock offering costs	(12,668)
Proceeds from the issuance of long term debt			17,164,600
Cash paid for debt issuance costs			(1,177,390)
Proceeds from the exercise of warrants		4,242,454	4,247,065
Proceeds from the issuance of common stock				10,000,000
Net cash provided by financing activities	(12,668)	4,242,454	20,234,275	10,000,000
Net increase in cash and restricted cash	(9,897,970)	580,541	2,288,539	19,794,888
Cash and restricted cash - beginning of period	24,655,828	22,367,289	22,367,289	2,572,401
Cash and restricted cash - end of period	14,757,858	22,947,830	24,655,828	22,367,289
Cash paid for taxes
Cash paid for interest		1,974
Supplemental disclosure of non-cash investing and financing activity:
Cashless exercise of options				19
Capitalized software included in accrued expense	807,218
Acquisition of noncontrolling interest	4,695,437
Special voting preferred stock issued in business combination	25,203,490
Conversion of exchangeable shares to common stock	$ 4,798,271
Stock-based compensation capitalized as software development			87,104
Assets acquired and liabilities assumed in business combinations and reverse merger:
Accounts receivable			77,505
Prepaid expenses and other current assets			27,860	35,292
Fixed assets			2,410
Intangible assets			8,010,000
Goodwill			20,254,309
Accounts payable and accrued liabilities			1,441,062
Deferred revenue			31,220
Contingent consideration			$ 1,387,000

Description of Business, Liquid

Description of Business, Liquidity and Capital Resources	3 Months Ended	12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business, Liquidity and Capital Resources	Note 1 - Description of Business, Liquidity and Capital Resources Description of Business Akerna Corp., herein referred to as we, our or Akerna, through our wholly owned subsidiaries MJ Freeway, LLC, or MJF, Trellis Solutions, Inc., or Trellis, Ample Organics, Inc, or Ample, and solo sciences, inc, or Solo, provides enterprise software solutions that enable regulatory compliance and inventory management. Our proprietary, broad and growing suite of solutions are adaptable for industries in which interfacing with government regulatory agencies for compliance purposes is required, or where the tracking of organic materials from seed or plant to end products is desired. We develop products intended to assist states in monitoring licensed businesses’ compliance with state regulations and to help state-licensed businesses operate in compliance with such laws. We provide our commercial software platforms, MJ Platform ® ® ® ™ ® ™ We consult with clients on a wide range of areas to help them successfully maintain compliance with state laws and regulations. We provide project-focused consulting services to clients who are initiating our expanding their cannabis business operations or are interested in data consulting engagements with respect to the legal cannabis industry. Our consulting engagements include service offerings focused on compliance requirement assessments, readiness and best practices, compliance monitoring systems, application processes, inspection readiness and business plan and compliance reviews. We typically provide our consulting services to clients in emerging markets who are seeking consultation on newly introduced licensing regimes and assistance with the regulatory compliant build-out of operations. Fiscal Year-End On September 25, 2020, our Board of Directors adopted resolutions to change our fiscal year-end from June 30 to December 31, effective for the year ending December 31, 2020. We will cover the transition period from July 1, 2020 to December 31, 2020 by filing an Annual Report on Form 10-K for the transition year ending December 31, 2020. Liquidity and Capital Resources Since our inception, we have incurred recurring operating losses, used cash in operations, and relied on capital raising transactions to continue ongoing operations. During the three months ended September 30, 2020, we incurred a loss from operations of $5.5 million and used cash in operations of $4.2 million. As of September 30, 2020, we had cash of $14.3 million, excluding restricted cash, and working capital of $0.9 million. During the quarter ended September 30, 2020, the Company incurred a number of one-time, non-recurring expenses of approximately $1.1 million. These expenses include business combination expenses, restructuring and other non-recurring charges. Additionally, on October 30, 2020, we closed on the public offering of 5 million shares of common stock with proceeds of approximately $11.0 million net of offering costs, which will be used for general corporate purposes. During the three months ended September 30, 2020 we implemented a number of cost reduction initiatives reducing costs and identifying costs savings that we expect to result in annual savings of an additional $3.0 million to $4.0 million. As a result, we expect that our current working capital is sufficient to fund our operations and commitments for a period of at least twelve months from the date these financial statements are issued. In the event the Company requires additional liquidity, the Company can further reduce or defer expenses. More specifically, the Company could implement certain discretionary cost reduction initiatives relating to our spend on employee travel and entertainment, consulting costs and marketing expenses, negotiate deferred salary arrangements, furlough employees or reduce headcount or negotiate extensions of payments of rent and utilities. The Company also believes it has access to capital through future debt or equity offerings and could be successful in renegotiating the maturity dates or conversion option relating to its current outstanding notes payable, although no assurance can be provided that we would be successful in these efforts. Further, the potential continues to exist that our $2 million PPP loan could be forgiven. Management will continue to evaluate our liquidity and capital resources.	Note 1 - Description of Business, Liquidity, and Capital Resources Description of Business Akerna Corp., herein referred to as we, us, our or Akerna, through our wholly-owned subsidiaries MJ Freeway, LLC, or MJF, Trellis Solutions, Inc., or Trellis, and solo sciences, inc., or Solo provides enterprise software solutions that enable regulatory compliance and inventory management. Our proprietary, broad and growing suite of solutions are adaptable for industries in which interfacing with government regulatory agencies for compliance purposes is required, or where the tracking of organic materials from seed or plant to end products is desired. We develop products intended to assist states in monitoring licensed businesses' compliance with state regulations and to help state-licensed businesses operate in compliance with such law. We provide our commercial software platform, MJ Platform®, and Trellis®, to state-licensed businesses, and our regulatory software platform, Leaf Data Systems®, to state government regulatory agencies. Through our controlled subsidiary, solo sciences inc., we provide an innovative, next-generation solution for state and national governments to securely track product and waste throughout the supply chain with solo*TAG ™ ™ We consult with clients on a wide range of areas to help them successfully maintain compliance with state laws and regulations. We provide project-focused consulting services to clients who are initiating or expanding their cannabis business operations or are interested in data consulting engagements with respect to the legal cannabis industry. Our advisory engagements include service offerings focused on compliance requirement assessments, readiness and best practices, compliance monitoring systems, application processes, inspection readiness, and business plan and compliance reviews. We typically provide our consulting services to clients in emerging markets that are seeking consultation on newly introduced licensing regimes and assistance with the regulatory compliant build-out of operations. Liquidity and Capital Resources Since our inception, we have incurred recurring operating losses, used cash in operations, and relied on capital raising transactions to continue ongoing operations. Although we have continuing negative cash flow from operations, the cash outflow since the Mergers is partially attributable to approximately $4.1 million in costs incurred in connection with specific transactions, including the Mergers, acquisitions completed or expected to close within the next twelve months and the issuance of debt. We implemented a cost reduction initiative and achieved a reduction in cash used in operations in excess of $1.0 million between the third and fourth quarters of fiscal year 2020. Subsequent to year end we implemented phase two of that initiative, the cost-cutting measures included reduction in headcount, as our business has matured we have been able to streamline our operations, we also determined to forego certain costs, which have not historically yielded sufficient returns. On June 8, 2020, we authorized a new series of senior secured convertible notes with net proceeds of $13.8 million after debt issuance costs. We anticipate our current cash balances will be sufficient to meet the working capital requirements for the next twelve months. From time to time, we may pursue various strategic business opportunities. These opportunities may include investment in or ownership of additional technology companies through direct investments, acquisitions, joint ventures, and other arrangements. We can provide no assurance that we will successfully identify such opportunities or that, if we identify and pursue any of these opportunities, any of them will be consummated. Consequently, we may raise additional equity or debt capital or enter into arrangements to secure the necessary financing to fund the completion of such strategic business opportunities, although no assurance can be provided that we will be successful in completing a future capital raise. The sale of additional equity could result in additional dilution to our existing stockholders, and financing arrangements may not be available to us, or may not be available in sufficient amounts or on acceptable terms. Our future operating performance will be subject to future economic conditions and to financial, business, and other factors, many of which are beyond our control.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended	12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 - Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. Certain footnotes and other financial information normally required by accounting principles generally accepted in the United States of America, or GAAP, have been condensed or omitted in accordance with such rules and regulations. In management's opinion, these condensed consolidated financial statements have been prepared on the same basis as our annual consolidated financial statements and notes thereto and include all adjustments, consisting of normal recurring items, considered necessary for the fair presentation. The operating results for the three months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the fiscal year transition period comprised of six months ending December 31,2020. The condensed consolidated balance sheet for the year ended June 30, 2020, has been derived from our audited financial statements at that date but does not include all disclosures and financial information required by GAAP for complete financial statements. The information included in this quarterly report on Form 10-Q should be read in conjunction with our consolidated financial statements and notes thereto for the year ended June 30, 2020, which were included in our annual report on Form 10-K filed on September 29, 2020. Principles of Consolidation Our accompanying condensed consolidated financial statements include the accounts of Akerna, our wholly owned subsidiaries and those entities in which we otherwise have a controlling financial interest. All significant intercompany balances and transactions have been eliminated in consolidation. We evaluate our ownership interests, contractual rights and other interests in entities to determine if the entities are variable interest entities, or VIEs, when we have a variable interest in those entities. Generally, a VIE is a legal entity in which the equity investors do not have the characteristics of a controlling financial interest or the equity investors lack sufficient equity at risk for the entity to finance its activities without additional subordinated financial support. These evaluations can be complex and involve judgment and the use of estimates and assumptions based on available historical information. If we determine that we hold a variable interest in a VIE and we are the primary beneficiary of the VIE, we must consolidate the VIE in our financial statements. In determining whether we are the primary beneficiary of a VIE, we consider qualitative and quantitative factors, including, but not limited to: which activities most significantly impact the VIE's economic performance and which party controls such activities; the amount and characteristics of our investment; the obligation or likelihood for us or other investors to provide financial support; and the similarity with and significance to our business activities and the business activities of the other investors. Significant judgments related to these determinations include estimates about the current and future fair values and performance of these VIE's operations and general market conditions. We determine whether we are the primary beneficiary of a VIE upon our initial involvement with the VIE and reassess our status on an ongoing basis. Segment Reporting Our chief operating decision maker reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance and information for different revenue streams is not evaluated separately. As such, the Company has one operating segment, and the decision-making group is the senior executive management team. In the following table, revenue is disaggregated by primary geographical markets and revenue source. For the Three Months Ended 2020 2019 Primary geographical markets: United States $ 2,285,211 $ 3,054,670 Canada 1,270,109 28,385 Other 158,684 109,835 Total $ 3,714,004 $ 3,192,890 As of As of Long-lived assets: United States $ 10,170,265 $ 10,254,374 Canada 5,345,092 - Total $ 15,515,357 $ 10,254,374 Use of Estimates The preparation of our condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts included in the financial statements and accompanying notes thereto. Actual results could differ materially from those estimates. Accounts Receivable, Net We maintain an allowance for doubtful accounts equal to the estimated uncollectible amounts based on our historical collection experience and review of the current status of trade accounts receivable. The allowance for doubtful accounts was $0.2 million as September 30, 2020 and $0.2 million as of June 30, 2020. Concentrations of Credit Risk We grant credit in the normal course of business to customers in the United States. We periodically perform credit analysis and monitor the financial condition of our customers to reduce credit risk. During the three months ended September 30, 2020, and 2019, one government client accounted for 17 % and 24% of total revenues, respectively. As of September 30, 2020, Goodwill Impairment Assessment We evaluate and test the recoverability of our goodwill for impairment at least annually during October of each year or more often if circumstances indicate that goodwill may not be recoverable. To date, we have not recorded any impairment of our goodwill. Foreign Currency Translation We have Canadian operations with Canadian Dollar as the functional currency. Foreign exchange gains and losses and translation adjustments, which result from the process of remeasuring foreign currency transactions into the appropriate functional currency, were immaterial during the quarter ended September 30, 2020. Supplemental Information Regarding Noncash Investing and Financing Activities During the three months ended September 30, 2020, we acquired 100% of the outstanding equity interest in Ample Organics, Inc., or Ample, in exchange for Akerna common stock valued at $25.2 million, please refer to Note 3 for additional information about the transaction and a schedule of the assets acquired and liabilities assumed in conjunction with this transaction Stock-Based Compensation We measured stock-based compensation based on the fair value of the share-based awards on the date of grant and recognize the related costs on a straight-line basis over the requisite service period, which is generally the vesting period. During the three months ended September 30, 2020, we granted 451,925 shares of Restricted Stock Units at an aggregate grant date fair value of approximately $2.2 million, vesting equally over four years. Reclassifications and Revisions Certain prior year financial statement amounts have been reclassified for consistency with the current year presentation. Additionally, certain prior year financial statement amounts have been revised to correct misstatements in the prior year, please refer to Note 9 for additional information regarding the corrections. Recent Accounting Pronouncements The Financial Accounting Standards Board, or the FASB, has issued guidance to simplify the remeasurement of goodwill when impairment is identified. Under existing guidance we would have to perform procedures to determine the fair value of our assets and liabilities as of the testing date in a manner similar to the procedures necessary to allocate purchase price to acquired assets and liabilities in a business combination. Under the new guidance, the goodwill impairment charge is equal to the excess of the carrying value of the reporting unit to which goodwill is assigned and the fair value of that reporting unit. We have elected to adopt the guidance early effective July 1, 2020 and will utilize this approach if necessary when we perform our annual goodwill impairment test. The FASB has issued guidance related to the accounting for share-based compensation to nonemployees, which eliminates the separate accounting model for nonemployee share-based payment awards and generally requires companies to account for share-based payment transactions with nonemployees in the same way as share-based payment transactions with employees. Under the new guidance, nonemployee share-based payment transactions are measured at the grant-date fair value and are no longer remeasured at the then-current fair values at each reporting date until the share options have vested. The amended guidance is effective for our fiscal year end transition financial statements for the six months ending December 31, 2020 and for interim periods beginning on January 1, 2021. We have completed our implementation procedures and concluded that there will be no material impact to our results of operations or financial condition as a result of this new standard. The FASB has issued guidance to revise accounting for revenue from contracts with customers, which supersedes the revenue recognition requirements and industry-specific guidance currently in effect for us. The new revenue standard requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. The new revenue standard is effective for our fiscal 2021 annual reporting period and for interim periods thereafter. The new revenue standard allows for either full retrospective or modified retrospective adoption. We will adopt the new standard using the modified retrospective approach and anticipate that the timing of recognition of incremental costs of obtaining contracts will be the most significant change to our results of operations upon adoption. As a result of our announced change in fiscal year end to December 31, 2020, as further discussed in Note 1, we will adopt the new standard in our transition period financial statements for the six months ending December 31, 2020. We are in the process of finalizing our implementation of this standard and expect to record a cumulative catch up adjustment to defer certain direct contract costs that have previously been recognized as expense as incurred, Additionally, we expect to adjust the recognition pattern for certain implementation fees earned in connection with government contracts. The FASB has issued new guidance related to the accounting for leases. The new standard establishes a right-of-use model that requires a lessee to record a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the statement of operations. Following our change in fiscal year effective on December 31, 2020, the new standard is effective for us beginning with our fiscal year ending December 31, 2022 and in interim periods thereafter. We have limited assets subject to operating lease and therefore expect the adoption of the new standard to result in the recognition of right of use assets and lease liabilities for any office or vehicle leases in effect at that date, we do not expect a significant impact to our results of operations. The FASB has issued guidance to introduce a new model for recognizing credit losses on financial instruments based on estimated current expected credit losses, or CECL. Under the new standard, an entity is required to estimate CECL on trade receivables at inception, based on historical information, current conditions, and reasonable and supportable forecasts. Following our change in fiscal year-end effective December 31, 2020, the new guidance is effective for us beginning on January 1, 2023. We are evaluating the impact of adoption of the new standard on our consolidated financial statements. The FASB has issued guidance regarding whether internal-use software development costs should be capitalized or charged to expense. Depending upon on the nature of the costs and the project stage in which they are incurred. Capitalized development costs are subject to amortization and impairment guidance consistent with existing internal-use software development cost guidance. Following our change in fiscal year end effective December 31, 2020, the guidance is applicable for us for the year ending December 31, 2021 and in interim periods thereafter, with early adoption permitted, including adoption in an interim period. We are evaluating the impact of adoption of the new standard on our financial statements. The FASB has issued guidance clarifying the interactions between various standards governing investments in equity securities. The new guidance addresses accounting for the transition into and out of the equity method and measurement of certain purchased options and forward contracts to acquire investments. The standard is effective for us for annual and interim periods beginning on January 1, 2022, with early adoption permitted. Adoption of the standard requires changes to be made prospectively. We do not anticipate a significant impact to our financial statements as a result of this new guidance.	Note 2 - Summary of Significant Accounting Policies Basis of Presentation The accompanying financial statements and related notes reflect the historical results of MJF prior to the mergers completed in June 2019, or the Mergers, with MTech Acquisition Corp., or MTech, and other related entities, which resulted in the combined company and do not include the historical results of MTech prior to the completion of the Mergers. The consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States, or GAAP, and our reporting currency is the United States Dollar. Principles of Consolidation Our accompanying consolidated financial statements include the accounts of Akerna, our wholly-owned subsidiaries, and those entities in which we otherwise have a controlling financial interest. All significant intercompany balances and transactions have been eliminated in consolidation. We evaluate our ownership interests, contractual rights, and other interests in entities to determine if the entities are variable interest entities or VIEs when we have a variable interest in those entities. Generally, a VIE is a legal entity in which the equity investors do not have the characteristics of a controlling financial interest or the equity investors lack sufficient equity at risk for the entity to finance its activities without additional subordinated financial support. These evaluations can be complex and involve judgment and the use of estimates and assumptions based on available historical information. If we determine that we hold a variable interest in a VIE and we are the primary beneficiary of the VIE, we must consolidate the VIE in our financial statements. In determining whether we are the primary beneficiary of a VIE, we consider qualitative and quantitative factors, including, but not limited to: which activities most significantly impact the VIE's economic performance and which party controls such activities; the amount and characteristics of our investment; the obligation or likelihood for us or other investors to provide financial support; and the similarity with and significance to our business activities and the business activities of the other investors. Significant judgments related to these determinations include estimates about the current and future fair values and performance of these VIE's operations and general market conditions. We determine whether we are the primary beneficiary of a VIE upon our initial involvement with the VIE and reassess our status on an ongoing basis. Use of Estimates The preparation of our consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts included in the financial statements and accompanying notes thereto. We base our estimates on assumptions that we believe to be reasonable under the circumstances, the results of which form a basis for making judgments about the carrying value of assets and liabilities that are not readily available from other sources. Actual results could differ from those estimates under different assumptions or conditions; however, we believe that our estimates are reasonable. Cash and Cash Equivalents We consider liquid instruments purchased with an original maturity of three months or less to be cash equivalents. There were no cash equivalents as of June 30, 2020 and 2019. We continually monitor our positions with, and the credit quality of, the financial institutions with which we invest. As of the balance sheet date, and periodically throughout the year, we have maintained balances in various operating accounts in excess of federally insured limits. As of June 30, 2020, approximately $23.5 million of our cash balances were uninsured. We have not experienced any losses on such accounts. Restricted Cash Restricted cash consists of funds that are contractually or legally restricted as to usage or withdrawal and is presented separately from cash and cash equivalents on our consolidated balance sheets. Our restricted cash serves as collateral for a letter of credit. Accounts Receivable, Net We maintain an allowance for doubtful accounts equal to the estimated uncollectible amounts based on our historical collection experience and review of the current status of trade accounts receivable. Receivables are written-off and charged against the recorded allowance when we have exhausted collection efforts without success. The allowance for doubtful accounts was $0.2 million as of June 30, 2020, and 2019. The allowance for doubtful accounts consists of the following activity for the years ended June 30, 2020 and 2019: 2020 2019 Allowance for doubtful accounts, beginning balance $ 190,088 $ 39,571 Additions: Bad debt expense 1,094,507 345,941 Deductions: Write-off uncollectable accounts (1,076,173 ) (195,424 ) Allowance for doubtful accounts, ending balance $ 208,422 $ 190,088 Concentrations of Credit Risk We grant credit in the normal course of business to customers in the United States. We periodically perform credit analysis and monitor the financial condition of our customers to reduce credit risk. During the year ended June 30, 2020 and 2019, government client accounted for % and 30% of total revenues, respectively. As of June 30, 2020, and 2019 government clients accounted for a total of 36% and 18%, and 34% and 24% of net accounts receivable, respectively. Equity Method Investments We make strategic investments in privately held equity securities of companies that provide technology solutions that are complementary to ours. When we can exert significant influence over, but do not control, the investee's operations, through voting rights or representation on the investee's board of directors, we account for the investment using the equity method of accounting. We record our share in the investee's earnings and losses in the consolidated statement of operations. We assess our investment for other-than-temporary impairment when events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable and recognize an impairment loss to adjust the investment to its then-current fair value. Intangible Assets Acquired through Business Combinations Intangible assets are amortized over their estimated useful lives. We evaluate the estimated remaining useful life of our intangible assets when events or changes in circumstances indicate an adjustment to the remaining amortization may be needed. We similarly evaluate the recoverability of these assets upon events or changes in circumstances indicate a potential impairment. Recoverability of these assets is measured by comparing the carrying amount of each asset to the future undiscounted cash flows the asset is expected to generate. If the undiscounted cash flows used in the test for recoverability are less than the carrying amount of these assets, the carrying amount of such assets is reduced to fair value. There were no impairments of intangible assets during the year ended June 30, 2020, or 2019. Goodwill Impairment Assessment We evaluate and test the recoverability of our goodwill for impairment at least annually during October of each year or more often if circumstances indicate that goodwill may not be recoverable. Software Development Costs Costs incurred during the application development stage of a newly developed application and costs we incur to enhance our existing platforms that meet certain criteria are subject to capitalization and subsequent amortization. Product development stage costs were approximately $3.2 million during the year ended June 30, 2020. Product development costs are primarily comprised of personnel costs such as payroll and benefits, vendor costs, and other costs directly attributable to the project. We capitalize costs only during the development phase. Any costs in connection to planning, design, and maintenance subsequent to release are expensed as incurred. We amortize software development costs over the expected useful life of the specific application, generally 2-5 years. We evaluate capitalized software development costs for impairment when there is an indication that the unamortized cost may not be recoverable. Fair Value of Financial Instruments GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Under this guidance, we are required to classify certain assets and liabilities based on the fair value hierarchy, which groups fair value-measured assets and liabilities based upon the following levels of inputs: ● Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; ● Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; ● Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity). The fair value of financial instruments is the amount at which the instrument could be exchanged in a current transaction between willing parties. The carrying values of financial instruments such as accounts receivable accounts payable and accrued liabilities approximate fair value based on their short maturities. Please refer to Note 11 - Fair Value Measurements for additional information regarding the fair value of financial instruments that we measure at fair value, including senior secured convertible notes and contingent consideration. Fair Value Option The fair value option provides an election that allows a company to irrevocably elect to record certain financial assets and liabilities at fair value on an instrument-by-instrument basis at initial recognition. We have elected to apply the fair value option to certain convertible notes due to the complexity of the various conversion and settlement options available to both the Note Holders and Akerna. The convertible notes accounted for under the fair value option election are each a debt host financial instrument containing embedded features that would otherwise be required to be bifurcated from the debt-host and recognized as separate derivative liabilities subject to initial and subsequent periodic estimated fair value measurements in accordance with GAAP. Notwithstanding, When the fair value option election is applied to financial liabilities, bifurcation of an embedded derivative is no required, and the financial liability is initially measured at its issue-date estimated fair value and then subsequently remeasured at estimated fair value on a recurring basis as of each reporting period date. The portion of the change in fair value attributed to a change in the instrument-specific credit risk is recognized as a component of other comprehensive income and the remaining amount of the fair value adjustment is recognized as other income (expense) in our consolidated statement of operations. The estimated fair value adjustment is presented in a respective single line item within other income (expense) in the accompanying consolidated statement of operations because the change in fair value of the convertible notes was not attributable to instrument-specific credit risk. Revenue Recognition We derive our revenues primarily from the following sources: software revenues, which are primarily comprised of subscription fees from government and commercial customers accessing our enterprise cloud computing services and from customers paying for additional support beyond the standard support that is included in the basic subscription fees; and consulting services provided to operators interested in integrating our platform into their respective operations, such services include: assessing compliance requirements, monitoring systems and readiness; assisting with the application process; and evaluating the operator's inspection readiness and business plan. We commence revenue recognition when there is persuasive evidence of an arrangement, the service has been or is being provided to the customer, the collection of the fees is reasonably assured, and the amount of fees to be paid by the customer is fixed or determinable. Software Revenue Software revenue primarily consists of subscription revenue that is recognized ratably over the term of the contract, beginning when access to the applicable software is provided to the customer. We typically invoice customers at the beginning of the term, in multi-year, annual, quarterly, or monthly installments. When a collection of fees occurs in advance of service delivery, revenue recognition is deferred until such services commence. Revenue for implementation fees is recognized ratably over the expected term of the contract, including expected renewals. We include service level commitments to customers warranting certain levels of uptime reliability and performance and permitting those customers to receive credits if those levels are not met. In addition, customer contracts often include: specific obligations that require us to maintain the availability of the customer's data through the service and that customer content is secured against unauthorized access or loss, and indemnity provisions whereby we indemnify customers from third-party claims asserted against them that result from our failure to maintain the availability of their content or securing the same from unauthorized access or loss. To date, we have not incurred any material costs as a result of such commitments. Any such credits or payments made to customers under these arrangements are recorded as a reduction of revenue. Consulting Services Revenue Consulting services revenue consists of contracts with fixed terms and fee structures based upon the volume and activity or fixed-price contracts for consulting and strategic services. When these services are not combined with subscription revenues as a single unit of account, as discussed below, these revenues are recognized as services are rendered and accepted by the customer. Other Revenues We sell solo*TAG ™ ™ ™ ™ Cost of Revenue Cost of revenue consists primarily of costs related to providing subscription and other services to our customers, including employee compensation and related expenses for data center operations, customer support and professional services personnel, payments to outside technology service providers, security services, and other tools. Deferred Revenue Deferred revenue consists of payments received in advance of revenue recognition from subscription services. The deferred revenue balance is influenced by several factors, including seasonality, the compounding effects of renewals, contract duration, and invoice frequency. Deferred revenue that will be recognized during the succeeding twelve-month period is recorded as deferred revenue, which is a current liability on the accompanying consolidated balance sheets. Reclassifications Certain prior year financial statement amounts have been reclassified for consistency with the current year presentation. Income Taxes Income taxes are accounted for using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of other assets and liabilities. We provide for income taxes at the current and future enacted tax rates and laws applicable in each taxing jurisdiction. We use a two-step approach for recognizing and measuring tax benefits taken or expected to be taken in a tax return and disclosures regarding uncertainties in income tax positions. We recognize interest and penalties related to income tax matters in selling, general and administrative expenses in the consolidated statement of operations. We recognize deferred tax assets to the extent that its assets are more likely than not to be realized. In making such a determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, and results of recent operations. If we determine that we would be able to realize our deferred tax assets in the future in excess of its net recorded amount, we will make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes. Stock-Based Compensation We measured stock-based compensation based on the fair value of the share-based awards on the date of grant and recognize the related costs on a straight-line basis over the requisite service period, which is generally the vesting period. Segments Our chief operating decision maker reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance and information for different revenue streams is not evaluated separately. As such, we have a single operating segment. Recently Issued Accounting Pronouncements The Financial Accounting Standards Board, or the FASB, has issued guidance to revise accounting for revenue from contracts with customers, which supersedes the revenue recognition requirements and industry-specific guidance currently in effect for us. The new revenue standard requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. The new revenue standard is effective for our fiscal 2021 annual reporting period and for interim periods thereafter. The new revenue standard allows for either full retrospective or modified retrospective adoption. We will adopt the new standard using the modified retrospective approach and anticipate that the timing of recognition of incremental costs of obtaining contracts will be the most significant change to our results of operations upon adoption. The FASB has issued new guidance related to the accounting for leases. The new standard establishes a right-of-use model that requires a lessee to record a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the statement of operations. The new standard is effective for us in our fiscal year beginning in 2022. We are evaluating the impact of the adoption of the new standard on our consolidated financial statements and do not anticipate a significant impact on our results of operations. The FASB has issued guidance to introduce a new model for recognizing credit losses on financial instruments based on estimated current expected credit losses, or CECL. Under the new standard, an entity is required to estimate CECL on trade receivables at inception, based on historical information, current conditions, and reasonable and supportable forecasts. The new guidance is effective for us in our fiscal year beginning in 2023. We are evaluating the impact of the adoption of the new standard on our consolidated financial statements. The FASB has issued guidance related to the accounting for share-based compensation to nonemployees, which eliminates the separate accounting model for nonemployee share-based payment awards and generally requires companies to account for share-based payment transactions with nonemployees in the same way as share-based payment transactions with employees. Under the new guidance, nonemployee share-based payment transactions are measured at the grant-date fair value and are no longer remeasured at the then-current fair values at each reporting date until the share options have vested. The amended guidance is effective for our annual financial statements for the fiscal year beginning on July 1, 2020, and for interim periods beginning in the subsequent fiscal year. We do not anticipate the adoption of this guidance to have a significant effect on our results of operations. The FASB has issued guidance regarding when internal-use software development costs should be capitalized or charged to expense. Depending upon the nature of the costs and the project stage in which they are incurred. Capitalized development costs are subject to amortization and impairment guidance consistent with existing internal-use software development cost guidance. The guidance is applicable for us in our fiscal year beginning in 2023 with early adoption permitted, including adoption in an interim period. We are evaluating the impact of the adoption of the new standard on our financial statements. The FASB has issued guidance clarifying the interactions between various standards governing investments in equity securities. The new guidance addresses accounting for the transition into and out of the equity method and measurement of certain purchased options and forward contracts to acquire investments. The standard is effective for us for annual and interim periods in our fiscal year beginning in 2022, with early adoption permitted. Adoption of the standard requires changes to be made prospectively. We are evaluating the impact of adoption of the new standard on our consolidated financial statements.

Significant Transactions

Significant Transactions	3 Months Ended	12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020
Significant Transactions [Abstract]
Significant Transactions	Note 3 – Significant Transactions Business Combinations On July 7, 2020, we completed the acquisition of Ample Organics ("Ample"), Ample provides a seed-to-sale platform to clients in Canada, which offers tracking, reporting, and compliance tools to cannabis cultivators, processors, sellers, and clinics. We acquired 100% of the stock of Ample Organics by issuing 3.3 million exchangeable shares of one of our wholly-owned subsidiaries. The exchangeable shares may be exchanged, at the option of the holder, for shares of Akerna common stock on a one-for-one basis, therefore the exchangeable shares issued were valued at $7.65 per share, the closing price of an equivalent share of Akerna common stock, for an aggregate value of $25.2 million. The exchangeable shares are economically equivalent to shares of Akerna common stock. In addition to the stock consideration, we paid $5.7 million in cash, which was used to settle all of Ample's then outstanding debt and transaction costs. The agreement provides for contingent consideration of up to CAD$10,000,000, payable in exchangeable shares, payable if Ample's Recurring Revenue recognized during the 12 months after the acquisition date is CAD$9,000,000 or more. The contingent consideration amount is reduced by an amount equal to the product of CAD$6.67 multiplied by the difference between CAD$9,000,000 and the amount of Recurring Revenue realized during the 12 months following the acquisition. The contingent consideration was recorded as the estimated fair value of $0.8 million as of the acquisition date and will be adjusted to the estimated fair value in each subsequent reporting period until settlement. The preliminary fair value of consideration transferred consisted of the following (in thousands): Preliminary Common shares issued $ 25,203 Cash 5,724 Contingent consideration 817 Total preliminary fair value of consideration transferred $ 31,744 We incurred $1.0 million of transaction costs directly related to the acquisition that is reflected in selling, general and administrative expenses in our condensed consolidated statements of operations. The following table summarizes the preliminary fair values of assets acquired and liabilities assumed as of the date of acquisition (in thousands): Preliminary Cash $ 445 Accounts receivable 917 Prepaid expenses 149 Intangible assets and goodwill 30,433 Furniture, fixtures and equipment 1,327 Accounts payable and accrued expenses (978 ) Deferred revenue (549 ) Net assets acquired $ 31,744 The excess of purchase consideration over the preliminary fair value of assets acquired and liabilities assumed was recorded as goodwill, which is primarily attributed to the assembled workforce and expanded market opportunities, for which there is no basis for U.S. income tax purposes. The fair values assigned to identifiable assets acquired and liabilities assumed are preliminary based on management's estimates and assumptions and will change as additional information is received. We expect to finalize the valuation as soon as practicable, but no later than one year from the acquisition date. The amounts of Ample's revenue and net loss included in our condensed consolidated statement of operations from the acquisition date of July 7, 2020, to September 30, 2020 were $1.2 million and $0.4 million, respectively. Pro Forma Financial Information The following unaudited pro forma financial information summarizes the combined results of operations for Akerna, Trellis, Solo, and Ample as though the companies were combined as of the beginning of our fiscal 2019 (in thousands): Three Months Ended 2020 2019 Revenues $ 3,790 $ 4,130 Net loss $ (4,686 ) $ (4,185 ) The pro forma financial information for all periods presented above has been calculated after adjusting the results of Solo, Trellis, and Ample to reflect the business combination accounting effects resulting from this acquisition, including the amortization expense from acquired intangible assets as though the acquisition occurred as of the beginning of the Company's fiscal year 2019. As noted above, the allocation is preliminary and changes to the value of the contingent consideration and finalization of our valuation could result in changes to the amount of amortization expense from acquired intangible assets included in the pro forma financial information presented above. The Akerna historical condensed consolidated financial statements have been adjusted in the pro forma combined financial statements to give effect to pro forma events that are directly attributable to the business combination and factually supportable. The pro forma financial information is for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition had taken place at the beginning of the Company's fiscal 2019. Special Voting Preferred Stock and Exchangeable Shares In connection with the Ample acquisition, we entered into agreements with our wholly-owned subsidiary and the Ample shareholder representative that resulted in the issuance of a single share of our special voting preferred stock, for the purpose of ensuring that each Exchangeable Share is substantially the economic and voting equivalent of a share of Akerna common stock, and, following the registration of the Akerna shares issuable upon exchange of the Exchangeable Shares under the Securities Act of 1933, ensuring that each Exchangeable Share is exchangeable on a one-for-one basis for a share of Akerna common stock, subject to certain limitations. As a result of these agreements and the issuance of the special voting preferred stock, each holder of Exchangeable Shares effectively has the ability to cast votes along with holders of Akerna common stock. Additionally, these agreements grant exchange rights to the holders of exchangeable shares upon the event of our liquidation, dissolution or winding up. The special voting preferred stock has a par value of $0.0001 per share and a preference in liquidation of $1.00. The special voting preferred stock entitles the holder to an aggregate number of votes equal to the number of the exchangeable shares issued and outstanding from time to time and which we do not own. The holder of the special voting preferred stock and the holders of shares of Akerna common stock will both together as a single class on all matters submitted to a vote of our shareholders. At such time as the special voting preferred stock has not votes attached to it, the share shall be automatically cancelled. The exchangeable shares do not have a par value. On September 1, 2020, several Ample shareholders exchanged a total of 627,225 exchangeable shares with a value of $4,798,271 for the same number of shares of Akerna common stock. The exchange was accounted for as an equity transaction and we did not recognize a gain or loss on this transaction. As of September 30, 2020, there were a total of 2,667,349 Exchangeable Shares issued and outstanding.	Note 3 – Significant Transactions Business Combinations Trellis Solutions, Inc. On April 8, 2020, we acquired Trellis, a cannabis cultivation management and compliance software company in an all-stock transaction. Our estimated acquisition date fair value of the consideration transferred for Trellis was as follows (in thousands): Common shares issued $ 2,531 Contingent consideration 998 Total estimated fair value of consideration $ 3,529 We incurred $0.1 million We issued 349,650 shares of our common stock valued at $7.24 Our purchase price allocation is preliminary as additional information may come to our attention regarding the acquisition date value of assets acquired and liabilities assumed that could require measurement period adjustments to this allocation. The following table summarizes our preliminary estimated fair values of assets acquired and liabilities assumed as of the date of acquisition (in thousands): Cash $ 21 Accounts receivable, net 77 Other assets 6 Acquired technology 210 Acquired trade name 80 Customer relationships 220 Goodwill 3,229 Accounts payable and accrued expenses (283 ) Deferred revenue (31 ) Net assets acquired $ 3,529 The excess of purchase consideration over the fair value of net tangible and intangible assets acquired was recorded as goodwill, which is primarily attributed to the assembled workforce and expanded market opportunities, for which there is no basis for U.S. income tax purposes. The amounts of Trellis's revenue and net loss included in our consolidated statement of operations from the acquisition date of April 10, 2020 to June 30, 2020 were $216,000 and $17,000, respectively. solo sciences, inc. On January 15, 2020, we closed on a stock purchase agreement with substantially all of the shareholders of Solo pursuant to which we acquired all right, title, and interest in 80.4% of the issued and outstanding capital stock of Solo, calculated on a fully diluted basis. As a result of our initial investment, Solo became a controlled subsidiary and we commenced consolidation of Solo on January 15, 2020. The estimated acquisition date fair value of the consideration transferred for Solo was $17.9 million. During the fourth quarter of fiscal 2020, we completed the preliminary valuation of the contingent consideration and recorded a measurement period adjustment to reflect this liability on our balance sheet. The estimated fair value of consideration recorded consisted of the following (in thousands): Common shares issued $ 17,550 Contingent consideration 389 Total estimated fair value of consideration $ 17,939 We incurred $0.3 million of transaction costs directly related to the acquisition, which is reflected in general and administrative expenses in our consolidated statement of operations. We exchanged 1,950,000 shares of our common stock, valued at $9.00 per share, the closing price of a share of our common stock on the date of acquisition. In addition to the stock consideration, we agreed to pay contingent consideration in the form of fees payable to the legacy Solo shareholders equal to the lesser of (i) $0.01 per solo*TAG ™ ™ ™ ™ We also acquired an option to acquire the noncontrolling interests in Solo during the 12 months following the close for either cash or shares. Beginning with the expiration of our option, the noncontrolling interests in Solo have a 3-month option to acquire between 40% and 55% of Solo back from us for cash. On July 31, 2020, we entered into an amendment to the stock purchase agreement to exercise our option to acquire the noncontrolling interests in Solo, for 800,000 shares of our common stock, this transaction will be recorded as an equity transaction, with no effect to the value of the assets acquired or liabilities assumed. In connection with this amendment, the selling shareholders agreed to cancel the contingent consideration in the future and waived a right to any amount that would have been earned prior to the amendment. Because the amendment occurred subsequent to our fiscal year-end, the liability remains recorded as of June 30, 2020, the liability will be written off upon the during our next fiscal quarter. During the fourth quarter 2020, we obtained additional information regarding the valuation of the assets acquired and liabilities assumed. We have recorded a measurement period adjustment to allocate the acquisition price to intangible assets, goodwill, accrued liabilities, and the fair value of noncontrolling interests. As we finalize this valuation, we may have additional adjustments to the allocated values. The following table summarizes the preliminary estimated fair values of assets acquired and liabilities assumed as of the date of acquisition (in thousands): Cash $ 101 Prepaid expenses and other assets 22 Furniture, fixtures, and equipment 2 Acquired technology 7,160 Acquired trade name 340 Goodwill 17,025 Accounts payable and accrued liabilities (1,158 ) Fair value of noncontrolling interests (5,554 ) Net assets acquired $ 17,938 The excess of purchase consideration over the fair value of net tangible and intangible assets acquired was recorded as goodwill, which is primarily attributed to expanded market opportunities, for which there is no basis for U.S. income tax purposes. The amounts of Solo's revenue and net loss included in our condensed consolidated statement of operations from the acquisition date of January 15, 2020 to June 30, 2020 were $23,000 and $1,471,000, respectively. Pro Forma Financial Information The following unaudited pro forma financial information summarizes the combined results of operations for Akerna, Trellis, and Solo, as though the companies were combined as of the beginning of our fiscal 2019: June 30, 2020 2019 Revenues $ 13,584 $ 12,220 Net loss (20,589 ) (15,884 ) The pro forma financial information for the periods presented above has been calculated after adjusting the results of Solo and Trellis to reflect the business combination accounting effects resulting from these acquisitions, including the amortization expense from acquired intangible assets as though the acquisitions occurred as of the beginning of our fiscal year 2020. As noted above, the allocation is preliminary and finalization of our valuation could result in changes to the amount of amortization expense from acquired intangible assets included in the pro forma financial information presented above. The Akerna historical consolidated financial statements have been adjusted in the pro forma combined financial statements to give effect to pro forma events that are directly attributable to the business combinations and factually supportable. The pro forma financial information is for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition had taken place at the beginning of our 2019 fiscal year. Ample Organics On July 7, 2020, we completed the acquisition of Ample Organics ("Ample"), Ample provides a seed-to-sale platform to clients in Canada, which offers tracking, reporting, and compliance tools to cannabis cultivators, processors, sellers, and clinics. We acquired 100% of the stock of Ample Organics for 3.3 million exchangeable shares of one of our wholly-owned subsidiaries. The exchangeable shares may be exchanged, at the option of the holder, for shares of Akerna common stock on a one-for-one basis, therefore the exchangeable shares issued were valued at $7.65 per share, the closing price of an equivalent share of Akerna common stock, $30.7 million was the aggregate value of the exchangeable shares. In addition to the stock consideration, we paid $5.5 million in cash, which was used to settle all of Ample's then outstanding debt. In addition to the stock and cash consideration, the agreement provides for contingent consideration of up to CAD$10,000,000, payable in exchangeable shares, payable if Ample's Recurring Revenue recognized during the 12 months after the acquisition date is CAD$9,000,000 or more. The contingent consideration amount is reduced by an amount equal to the product of CAD$6.67 multiplied by the difference between CAD$9,000,000 and the amount of Recurring Revenue realized during the 12 months following the acquisition. The contingent consideration will be recorded as the estimated fair value on the acquisition date and adjusted to estimated fair value in each subsequent reporting period until settlement. Due to the short period of time since the acquisition date and limitations on access to Ample information prior to the acquisition date, our initial accounting for the business combination is incomplete at this time. As a result, we are unable to provide amounts recognized as of the acquisition date for major classes of assets and liabilities acquired and resulting from the transaction, including the information required for contingencies, intangible assets, and goodwill. This information is expected to be reflected in our interim financial statements included in our quarterly report on Form 10-Q for the three months ending September 30, 2020. Reverse Merger On June 17, 2019, MTech and MJF consummated the Mergers contemplated by the Merger Agreement dated October 10, 2018, as amended. In connection with the closing of the Mergers, we changed our name from MTech Acquisition Holdings Inc. to Akerna Corp. The Merger Consideration was paid through the issuance of 6,520,099 shares of our common stock (the "Consideration Shares") to the former holders of MJF common units, preferred units, and profit interest units at a price equal to $10.16 per share. We allocated 283,010 fully vested shares of Akerna common stock and 215,063 shares of unvested restricted stock were allocated to the former holders of MJF profit interest units, which were accounted for as share-based compensation. As disclosed above, (a) 283,110 fully vested shares of common stock were allocated to the former holders of MJF profit interest units, resulting in the recognition of approximately $3.4 million on June 17, 2019 and approximately $2.1 million of compensation expense related to unvested restricted shares such profit interest units be recognized over the remaining vesting period of 3 years.

Fair Value

Fair Value	3 Months Ended	12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020
Fair Value Disclosures [Abstract]
Fair Value	Note 4 - Fair Value Contingent Consideration Solo In connection with our acquisition of Solo, the Solo selling shareholders received the potential to earn the contingent consideration, which was to be calculated as the lesser of (i) $0.01 per solo*TAG TM TM TM TM We recorded the fair value of the liability in the condensed consolidated balance sheets under the caption "current contingent consideration" and recognized changes to the fair value of the liability against earnings or loss each reporting period until settlement. The fair value of the contingent consideration on the date of the acquisition of Solo was $389,000. In connection with our exercise of the option to acquire the remaining interest in Solo, the selling shareholders agreed to retrospectively and prospectively relieve the contingent consideration obligation. Therefore the settled value of the contingent consideration was $0. We have recorded a gain on settlement of the contingent consideration liability during the three months ended September 30, 2020 in general and administrative expenses in our condensed consolidated statement of operations. Ample In addition to the stock and cash consideration, the agreement provides for contingent consideration of up to CAD$10,000,000, payable in exchangeable shares, payable if Ample's Recurring Revenue recognized during the 12 months after the acquisition date is CAD$9,000,000 or more. The contingent consideration amount is reduced by an amount equal to the product of CAD$6.67 multiplied by the difference between CAD$9,000,000and the amount of Recurring Revenue realized during the twelve months following the acquisition. We record the fair value of the liability in the condensed consolidated balance sheets as contingent consideration payable and recognize changes to the liability against earnings or loss in general and administrative expenses in the condensed consolidated statements of operations. The fair value of the contingent consideration on the date of the acquisition of Ample was $817,000 is $817,000. Fair Value Option Election – Convertible Notes We issued Convertible Notes with a principal amount of $17.0 million at a purchase price of $15.0 million on June 9, 2020. We have elected to account for the Convertible Notes using the fair value option. Under the fair value option, the financial liability is initially measured at its issue-date estimated fair value and subsequently remeasured at its estimated fair value on a recurring basis at each reporting period date. The change in estimated fair value resulting from changes in instrument-specific credit risk is recorded in other comprehensive income as a component of equity. The remaining estimated fair value adjustment is presented as a single line item within other income (expense) in our condensed consolidated statement of operations under the caption, change in fair value of convertible notes. For the Convertible Notes, which are measured at fair value categorized within Level 3 of the fair value hierarchy, the following is a reconciliation of the fair values from June 30, 2020, to September 30, 2020: Fair value balance as of June 30, 2020 $ 14,131,000 Change in fair value reported in the statements of operations (778,000 ) Change in fair value reported in other comprehensive income 70,000 Fair value balance as of September 30, 2020 $ 13,423,000 The estimated fair value of the Convertible Notes as of June 30, 2020, and September 30, 2020, was computed using a Monte Carlo simulation, which incorporates significant inputs that are not observable in the market, and thus represents a Level 3 measurement as defined by GAAP. The unobservable inputs utilized for measuring the fair value of the Convertible Notes reflect our assumptions about the assumptions that market participants would use in valuing the Convertible Notes as of the issuance date and subsequent reporting period. We estimated the fair value by using the following key inputs to the Monte Carlo Simulation Model: Fair Value Assumptions - Convertible Notes September 30, June 30, Face value principal payable $ 17,000,000 $ 17,000,000 Original conversion price $ 11.50 $ 11.50 Value of Common Stock $ 3.64 $ 8.80 Expected term (years) 2.67 2.90 Volatility 68 % 45 % Market yield 28.0 % 23.9 % Risk free rate 0.1% to 0.2 % 0.2 %	Note 11 - Fair Value Contingent Consideration Solo In connection with our acquisition of Solo, the Solo selling shareholders have the potential to earn the contingent consideration, which is calculated as the lesser of (i) $0.01 per solo*TAG TM TM TM TM We record the fair value of the liability in the consolidated balance sheets under the caption "current contingent consideration" and recognize changes to the liability against earnings or loss in general and administrative expenses in the consolidated statements of operations. The fair value of the contingent consideration on the date of the acquisition of Solo was $389,000. The carrying amount at fair value of the aggregate liability for the contingent consideration recorded on the consolidated balance sheet at June 30, 2020 is $389,000. As such we have not recorded a change in the fair value of the contingent consideration during the year ended June 30, 2020. As discussed in Note 3, subsequent to year end, we reached an agreement with the Solo selling shareholders to eliminate any future obligation with respect to the contingent consideration and waive any contingent consideration that would have been due prior to amending the agreement. We utilized a Monte Carlo simulation model, which incorporates significant inputs that are not observable in the market, and thus represents a Level 3 measurement as defined in GAAP. The unobservable inputs utilized for measuring the fair value of the contingent consideration reflect our assumptions about the assumptions that market participants would use in valuing the contingent consideration as of the acquisition date and subsequent reporting period. Trellis In connection with our acquisition of Trellis, the Trellis selling shareholders have the potential to earn contingent consideration, which is calculated as five times the annualized revenue of certain customers generated in September 2020. The fair value of the contingent consideration on the date of acquisition of Trellis was $998,000. The carrying amount at the fair value of the liability for the contingent consideration recorded on our consolidated balance sheet as of June 30, 2020 was $0. We have recorded the change in the fair value of the contingent consideration during the year ended June 30, 2020 in general and administrative expenses in our consolidated statement of operations. We valued the contingent consideration using a probability-weighted discounted cash flow model, which incorporates inputs that are not observable in the market and thus represents a Level 3 measurement as defined in GAAP. The unobservable inputs utilized for measuring the fair value of the contingent consideration reflect management's own assumptions about the assumptions that market participants would use in valuing the contingent consideration as of the valuation date, as well as our knowledge of specific transactions that effect the calculation. Fair Value Option Election – Convertible Notes We issued Convertible Notes with a principal amount of $17.0 million at a purchase price of $15.0 million on June 9, 2020. We have elected to account for the Convertible Notes using the fair value option. Under the fair value option, the financial liability is initially measured at its issue-date estimated fair value and subsequently remeasured at estimated fair value on a recurring basis at each reporting period date. The change in estimated fair value resulting from changes in instrument specific credit risk is recorded in other comprehensive income as a component of equity. The remaining estimated fair value adjustment is presented as a single line item within other income (expense) in our consolidated statement of operations under the caption, change in fair value of convertible notes For the Convertible Notes, which are measured at fair value categorized within Level 3 of the fair value hierarchy, the following is a reconciliation of the fair values from June 9, 2020 (date of issuance) to June 30, 2020: Beginning fair value balance on issue date - June 9, 2020 $ 14,960,000 Change in fair value reported in the statements of operations (766,000 ) Change in fair value reported in other comprehensive income (63,000 ) Ending fair value balance - June 30, 2020 $ 14,131,000 The estimated fair value of the Convertible Notes as of their June 9, 2020 issue date and as of June 30, 2020, was computed using a Monte Carlo simulation, which incorporates significant inputs that are not observable in the market, and thus represents a Level 3 measurement as defined by GAAP. The unobservable inputs utilized for measuring the fair value of the Convertible Notes reflects our assumptions about the assumptions that market participants would use in valuing the Convertible Notes as of the issuance date and subsequent reporting period. We determined the fair value by using the following key inputs to the Monte Carlo Simulation Model: Fair Value Assumptions - Convertible Notes June 30, June 9, Face value principal payable $ 17,000,000 $ 17,000,000 Original conversion price $ 11.50 $ 11.50 Value of Common Stock $ 8.80 $ 10.28 Expected term (years) 2.9 3.0 Volatility 45.0 % 45.0 % Market yield (range) 23.9 % 23.3% to 23.4 Risk free rate 0.2 % 0.2 %

Balance Sheet Disclosures

Balance Sheet Disclosures	12 Months Ended
	Jun. 30, 2020
Balance Sheet Disclosures [Abstract]
Balance Sheet Disclosures	Note 4 - Balance Sheet Disclosures Prepaid expenses and other current assets as of June 30, 2020 and 2019 consisted of the following: 2020 2019 Software and technology $ 571,695 $ 237,930 Professional services, dues, and subscriptions 473,731 169,804 Insurance 105,814 159,940 Rental deposit 38,303 10,000 Other 25,798 — Total Prepaid Expenses and Other Current Assets $ 1,215,341 $ 577,674 Accounts payable and accrued liabilities as of June 30, 2020 and 2019 consisted of the following: 2020 2019 Accounts payable $ 1,443,895 $ 1,317,566 Professional fees 2,273,659 49,205 Sales taxes 59,825 36,358 Compensation 260,042 354,724 Contractors 782,366 19,557 Other 42,141 40,706 Total accounts payable and accrued liabilities $ 4,861,928 $ 1,818,116 The accrued compensation includes accrued executive bonuses of $128,000 and $215,000 as of June 30, 2020, and 2019, respectively.

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, Net	12 Months Ended
	Jun. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets, Net	Note 5 - Goodwill and Intangible Assets, Net Goodwill The following table reflects the changes in the carrying amount of goodwill during the year ended June 30, 2020: Balance as of June 30, 2019 $ — Additions due to acquisitions 20,254,309 Balance as of June 30, 2020 $ 20,254,309 Finite-lived Intangible Assets, Net Intangible assets as of June 30, 2020 consist of the following: Weighted average remaining amortization period (in years) Gross carrying amount Accumulated amortization Net Acquired developed technology 4.42 $ 7,370,000 $ (679,696 ) $ 6,690,304 Acquired trade names 7.40 420,000 (23,248 ) 396,752 Customer relationships 1.75 220,000 (24,475 ) 195,525 Other intangible assets, not yet placed into service N/A 211,394 — 211,394 Intangible assets $ 8,221,394 $ (727,419 ) $ 7,493,975 Capitalized software - In-service 1.86 2,852,044 (560,528 ) 2,291,516 Capitalized software - Work in Progress N/A 337,788 — 337,788 Total Capitalized Software 3,189,832 (560,528 ) 2,629,304 Total finite-lived intangible assets $ 11,411,226 $ (1,287,947 ) $ 10,123,279 We record amortization expense associated with acquired developed technology, acquired trade names, and customer relationships. The amortization expense of all finite-lived intangible assets, which includes capitalized software was $1.3 million for the year ended June 30, 2020. As of June 30, 2020, expected amortization expense relating to capitalized software and purchased intangible assets for each of the next five years and thereafter is as follows: Acquired Intangible Assets Capitalized Software 2021 $ 1,711,444 $ 1,325,851 2022 1,663,607 806,012 2023 1,490,511 63,838 2024 1,469,778 63,838 2025 813,444 31,977 Thereafter 133,797 — Total $ 7,282,581 $ 2,291,516

Long Term Debt

Long Term Debt	12 Months Ended
	Jun. 30, 2020
Debt Disclosure [Abstract]
Long Term Debt	Note 7 - Long Term Debt Long-term debt consisted of the following at June 30, 2020, we had no long-term debt as of June 30, 2019: Convertible Notes (at fair value) $ 14,131,000 PPP loan 2,204,600 Subtotal 16,335,600 Less: current maturities (6,135,364 ) Total long-term debt, less current portion $ 10,200,236 Senior Secured Convertible Notes On June 8, 2020, we entered into a Securities Purchase Agreement, or SPA, with two institutional investors, or the Note Holders, to sell a new series of senior secured convertible notes, or the Convertible Notes, of Akerna in a private placement to the Note Holders, in the aggregate principal amount of $17.0 million having an aggregate original issue discount of 12%, and ranking senior to all outstanding and future indebtedness of Akerna. The Convertible Notes were sold on June 9, 2020, with an original issue discount pursuant to which the Note Holders paid $880 per each $1,000 in principal amount of the Convertible Notes. The Convertible Notes do not bear interest except upon the occurrence of an event of default, in which event the applicable rate will be 15.00% per annum. The Convertible Notes mature on June 1, 2023, are payable in installments beginning on October 1, 2020, and may not be prepaid. The Convertible Notes are convertible at any time, at the election of the Holders and subject to certain limitations, into shares of common stock at a rate equal to the amount of principal, interest, if any, and unpaid late charges, if any, divided by a conversion price of $11.50. Under the terms of the Convertible Notes, the Convertible Notes are convertible at any time, in whole or in part, at the option of the holders thereof, into shares of common stock at a rate equal to the amount of principal, interest (if any) and unpaid late charges (if any), divided by a conversion price of $11.50. In connection with the occurrence of an event of default, the Holders of the Convertible Notes will be entitled to convert all or any portion of the Convertible Notes at an alternate conversion price equal to the lower of (i) the conversion price then in effect, or (ii) 80% of the lower of (x) the volume-weighted average price, or VWAP, of the common stock as of the trading day immediately preceding the applicable date of determination, or (y) the quotient of (A) the sum of the VWAP of the common stock for each of the two trading days with the lowest VWAP of the common stock during the ten (10) consecutive trading day period ending and including the trading day immediately prior to the applicable date of determination, divided by (B) two, but not less than $1.92. We have elected to use the fair value option to account for the Convertible Notes. The fair value of the Convertible Notes on issuance was recorded as $15.0 million. During the year ended June 30, 2020, the fair value of the Convertible Notes decreased by $0.8 million. Of the adjustment, a decrease of $0.1 million resulted from instrument-specific credit risk and was recognized as other comprehensive income and accumulated in equity and a decrease of $0.8 million was recognized as current period other expense in our consolidated statement of operations. As of June 30, 2020, the fair value of the Convertible Notes on our consolidated balance sheet was $14.1 million. Paycheck Protection Program Loan In April 2020, we were granted a loan, or the PPP Loan, from a lender in the aggregate amount of $2.2 million pursuant to the Paycheck Protection Program under the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act. The PPP Loan is evidenced by a promissory note dated April 21, 2020, the Note. The PPP Loan bears interest at a fixed rate of 1.0% per annum, with the first six months of interest deferred from the date of the Note, has an initial term of two years from the date of the Note, and is unsecured and guaranteed by the Small Business Administration. We may prepay up to 20% of the PPP Loan amount at any time prior to maturity with no prepayment penalties. We must pay all accrued interest if we prepay greater than 20% of the PPP Loan amount and the PPP Loan has been sold on the secondary market. The Note provides for customary events of default. The PPP Loan may be accelerated upon the occurrence of an event of default. The PPP Loan may be forgiven in accordance with the terms of the CARES Act. The principal amount of the PPP Loan not forgiven and accrued interest is to be repaid in 18 equal monthly installments beginning seven months from the date of the disbursement of the PPP Loan. We applied for the PPP Loan and received the proceeds from the PPP Loan prior to the issuance of the recent guidance from the United States Treasury Department and U.S. Small Business Administration on April 23, 2020. We are currently evaluating the impact this guidance has on Akerna and the PPP Loan. We are accounting for the PPP Loan as a liability and accrue interest expense using the effective interest method. The aggregate scheduled maturities of outstanding long-term debt obligations in subsequent years are as follows: Fiscal Year ending June 30, 2021 $ 6,844,620 2022 12,359,980 Aggregate maturities 19,204,600 Original issue discount on Convertible Notes (2,040,000 ) Unrealized change in fair value of Convertible Notes (829,000 ) Long term debt outstanding as of June 30, 2020 $ 16,335,600

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Jun. 30, 2020
Equity [Abstract]
Stockholders' Equity	Note 8 - Stockholders' Equity Common and Preferred Stock Upon the closing of the Merger, our certificate of incorporation was amended and restated to have one single class of common stock and 75,000,000 authorized shares of common stock, par value $0.0001 per share. We also entered into a series of securities purchase agreements with certain investors (the "PIPE Investors"), whereby we issued 901,074 shares of Class A common stock (the "Private Placement Shares") for an aggregate purchase price of $9.2 million (the "Private Placement"), which closed simultaneously with the consummation of the Mergers. Upon the closing of the Mergers, the Private Placement Shares were automatically converted into shares of Akerna common stock on a one-for-one basis. The proceeds received from the Mergers totaled approximately $18 million, which is net of $4.4 million of underwriting discounts and commissions and other expenses related to the Mergers. We also have 5,000,000 authorized shares of preferred stock, $0.0001 par value per share, of which none are issued and outstanding. The holders of common stock are entitled to one vote per share on all matters submitted to a vote of stockholders of the Company. Subject to the prior rights of all classes or series of stock at the time outstanding having prior rights as to dividends or other distributions, all stockholders are entitled to share equally in dividends, if any, as may be declared from time to time by the Board of Directors out of funds legally available. Subject to the prior rights of creditors of the Corporation and the holders of all classes or series of stock at the time outstanding having prior rights as to distributions upon liquidation, dissolution, or winding up of the Corporation, in the event of liquidation, the holders of Common Stock are entitled to share ratably in all assets remaining after payment of all liabilities. The stockholders do not have cumulative, preemptive rights, or subscription rights. Warrants In connection with MTech's initial public offering, we sold 5,750,000 units at a purchase price of $10.00 per unit, inclusive of 750,000 units sold to the underwriters on February 8, 2018, upon the underwriters' election to fully exercise their over-allotment option. Each unit consisted of one share of MTech's common stock and one warrant ("Public Warrant"). Each Public Warrant entitled the holder to purchase one share of MTech's common stock at an exercise price of $11.50. Upon the Mergers, the Public Warrants were converted to those of Akerna at the exchange ratio of one-for-one. A summary of the status of common stock warrants as of June 30, 2020 and the changes during the two years then ended, is presented in the following table: Shares Issuable Under Warrants Weighted-average Exercise Price Weighted Average Remaining Life Aggregate Intrinsic Value Outstanding as of July 1, 2018 5,993,750 $ 11.50 — $ — Issued 189,365 11.50 — — Exercised — — — — Expired/canceled — — — — Outstanding at June 30, 2019 6,183,115 $ 11.50 4.97 $ 2,473,000 Issued — — — — Exercised (369,311 ) — — — Expired/canceled — — — — Outstanding at June 30, 2020 5,813,804 $ 11.50 3.97 $ — There was no aggregate intrinsic value for the warrants outstanding as of June 30, 2020.

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Jun. 30, 2020
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	Note 9 - Stock-Based Compensation Restricted Shares and Restricted Stock Units On June 17, 2019, our stockholders considered and approved the 2019 Long Term Incentive Plan, or the Equity Incentive Plan, and reserved 1,040,038 shares of common stock for issuance thereunder. The Equity Incentive Plan was previously approved, subject to stockholder approval, by the board of directors of Akerna on January 23, 2019. The Equity Incentive Plan became effective immediately upon the Closing of the Mergers. On June 26, 2020, the stockholders approved an amendment to the Equity Incentive Plan and increased the shares authorized for issuance thereunder by 525,000 to 1,565,038. We grant restricted stock units, or RSUs, that are subject to time-based vesting and require continuous employment, typically over a period of four years from the grant date or the first day of the service period. Prior to the Mergers, MJF had Profit Interest Incentive Plan in place whereby it could grant Profits Interest Units, or PIUs, to employees or consultants and other independent advisors of the Company. PIUs granted under the Profits Interest Plan would generally vest once a year over four years commencing on the date granted or based on specified performance targets. MJF had the right, but not the obligation, to repurchase vested PIUs from holders upon their termination of employment. Unvested PIUs were to be forfeited upon termination of employment. If the holder was terminated for cause, as defined, all vested and unvested units would be forfeited. PIUs repurchased or canceled or forfeited by the award recipient were available for reissuance. Upon completion of the Mergers, the non-vested PIUs were exchanged for and became subject to restricted stock agreements, or Restricted Shares, with varying vesting terms that reflect the vesting conditions applicable to the individual PIUs at the time of the merger. We determined the PIUs represented a profit-sharing compensation arrangement that had value only upon a defined liquidating event. Accordingly, no value was accrued for the PIUs prior to the Mergers on June 17, 2019, which met the definition of a liquidating event. As a result, we recorded a one-time charge of approximately $3.4 million, which represented the charge associated with issuing fully vested shares of common stock in exchange for the PIUs. A summary of our unvested Restricted Shares and Restricted Stock Units ("RSUs") activity for the year ended June 30, 2020 is presented in the table below: Restricted Shares Restricted Stock Units Total Weighted Average Grant Date Fair Value Unvested as of June 30, 2019 215,063 — 215,063 $ 11.99 Granted — 571,229 571,229 7.24 Vested (88,659 ) (26,965 ) (115,624 ) 7.25 Forfeited (54,091 ) (78,470 ) (132,561 ) 10.83 Unvested as of June 30, 2020 72,313 465,794 538,107 $ 6.56 For the year ended June 30, 2020, we recognized stock-based compensation expense related to the ratable amortization of the unvested Restricted Shares and RSUs of $1.3 million. stock-based compensation expense is included in operating expenses and cost of sales on our consolidated statements of operations consistent with the allocation of other compensation arrangements. During the year ended June 30, 2020, we capitalized $0.1 million in stock-based compensation costs as software development cost. The $3.9 million of unrecognized costs as of June 30, 2020 related to Restricted Shares and RSUs will be ratably recognized over an estimated weighted average remaining vesting period of 3.1 years.

Loss Per Share

Loss Per Share	3 Months Ended	12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020
Earnings Per Share [Abstract]
Loss Per Share	Note 5 - Loss Per Share During the three months ended September 30, 2020, we used the two-class method to compute net loss per share because we issued securities other than common stock that is economically equivalent to a common share in that the class of stock has the right to participate in dividends should a dividend be declared payable to holders of Akerna common stock. These participating securities were the Exchangeable Shares issued by our wholly owned subsidiary in exchange for interest in Ample. The two-class method requires earnings for the period to be allocated between common stock and participating securities based on their respective rights to receive distributed and undistributed earnings. Under the two-class method, for periods with net income, basic net income per common share is computed by dividing the net income attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period. Net income attributable to common stockholders is computed by subtracting from net income the portion of current period earnings that the participating securities would have been entitled to receive pursuant to their dividend rights had all of the period's earnings been distributed. No such adjustment to earnings is made during periods with a net loss, as the holders of the Exchangeable Shares have no obligation to fund losses. Diluted net loss per common share is calculated under the two-class method by giving effect to all potentially dilutive common stock, including warrants, restricted stock awards, restricted stock units, and shares of common stock issuable upon conversion of our Convertible Notes. We analyzed the potential dilutive effect of any outstanding convertible securities under the "if-converted" method, in which it is assumed that the outstanding Exchangeable Shares and Convertible Notes are converted to shares of common stock at the beginning of the period or date of issuance, if later. We report the more dilutive of the approaches (two-class or "if-converted) as the diluted net loss per share during the period. The dilutive effect of unvested restricted stock awards and restricted stock units is reflected in diluted loss per share by application of the treasury stock method and is excluded when the effect would be anti-dilutive. The weighted-average number of shares outstanding used in the computation of diluted earnings per share does not include the effect of potential outstanding common shares that would have been anti-dilutive for the period. There were no potentially outstanding shares as of September 30, 2019. The table below details potentially outstanding shares on a fully diluted basis as of September 30, 2020 that were not included in the calculation of diluted earnings per share: Three Months Ended 2020 2019 Shares issuable upon exchange of Exchangeable Shares 2,667,349 — Shares of common stock issuable in upon conversion of Convertible Notes 1,542,632 — Warrants 5,813,804 5,814,205 Unvested restricted stock units 824,143 — Unvested restricted stock awards 64,296 215,063 Total 10,912,224 6,029,268	Note 10 - Loss Per Share Basic net loss per share is calculated by dividing net loss attributable to Akerna stockholders by the weighted-average number of shares of common stock outstanding. Diluted net loss per common share is calculated by giving effect to all potentially dilutive common stock, including warrants, restricted stock awards, restricted stock units, and shares issuable upon conversion of debt. The dilutive effect of outstanding awards is reflected in diluted earnings per share by application of the treasury stock method and excludes potential common stock when the effect would be anti-dilutive. The weighted-average number of shares outstanding used in the computation of diluted earnings per share does not include the effect of potential outstanding common shares that would have been anti-dilutive for the period. The table below details potentially outstanding shares on a fully diluted basis as of June 30, 2020 and 2019 that were not included in the calculation of diluted earnings per share and the weighted average amounts of potentially outstanding shares that would have been dilutive had we reported net income for the years ended June 30, 2020 and 2019. Fully Diluted Weighted Average for the Year Ended 2020 2019 2020 2019 Warrants 5,813,804 6,183,115 5,833,971 6,001,013 Restricted Stock Units 325,121 — 37,709 — Restricted Stock Awards 75,654 215,063 7,656 2,351 Shares of common stock issuable in upon conversion of Convertible Notes 1,936,845 — 111,130 — Total 8,151,424 6,398,178 5,990,466 6,003,364

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended	12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 6 - Commitments and Contingencies Operating Leases We lease office facilities and vehicles under non-cancelable operating leases. Rent expense for the three months ended September 30, 2020 and 2019, was $273,000 and $36,000, respectively. Future minimum lease payments under these leases for the remainder of the fiscal year transition period ending December 31, 2020 and each of the five years ending on December 31 thereafter are as follows: Three months ending December 31, 2020 $ 226,687 2021 918,847 2022 439,633 2023 421,418 2024 426,495 2025 464,575 Thereafter 983,731 Total $ 3,881,386 Litigation From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. We will accrue a liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. The accrual for a litigation loss contingency might include, for example, estimates of potential damages, outside legal fees and other directly related costs expected to be incurred. As of September 30, 2020, and through the date these financial statements were issued, there were no legal proceedings requiring recognition or disclosure in the financial statements.	Note 12 - Commitments and Contingencies Operating Leases We lease facilities and vehicles under non-cancelable operating leases. Rent expense for the years ended June 30, 2020 and 2019 was $299,629 and $151,458, respectively. Future minimum lease payments under these leases are $526,185 for the year ending June 30, 2021 and $305,214 for the year ending June 30, 2022. Letter-of-Credit As of June 30, 2020, and 2019, we had a standby letter-of-credit with a bank in the amount of $500,000. The standby letter of credit is collateralized by $500,000 of cash, which is classified as restricted cash on our consolidated balance sheets. The beneficiary of the letter-of-credit is an insurance company. Litigation From time to time, the Company may be involved in litigation relating to claims arising out of its operations in the normal course of business. The Company will accrue a liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of possible losses can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. The accrual for a litigation loss contingency might include, for example, estimates of potential damages, outside legal fees, and other directly related costs expected to be incurred. As of June 30, 2020 and 2019, respectively, there were no legal proceedings requiring recognition or disclosure in the financial statements. Employee Benefit Plan We have a 401(k) Plan (the "Plan") to provide retirement benefits for its employees. Employees may contribute up to a portion of their annual compensation to the Plan, limited to a maximum annual amount as updated annually by the IRS. We do not offer a match of employee contributions nor any discretionary contributions.

Income Taxes

Income Taxes	12 Months Ended
	Jun. 30, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Note 13 - Income Taxes We are the sole owner of MJF as of June 17, 2019, which is a disregarded entity for federal income taxes. Prior to June 17, 2019 MJF was treated as a partnership for U.S income tax purposes. Accordingly, prior to the business combination, our taxable income and losses were reported on the income tax returns of MJF's members. Therefore, no income tax is provided prior to June 17, 2019. On March 27, 2020 the Coronavirus Aid, Relief and Economic Security Act, or the CARES Act, was enacted in response to the COVID-19 pandemic. It was determined the CARES Act did not materially impact our tax provision as of June 30, 2020. The accounting for the business combinations of Solo and Trellis reflected in the accompanying financial statements is preliminary and is based upon estimates and assumptions that are subject to change within the measurement period (up to one year from the acquisition date). The measurement period remains open pending the completion of valuation procedures related to the acquired assets and assumed liabilities, intangible assets and income taxes. The following table sets forth the expense or (benefit) for income taxes: June 30, 2020 2019 Income tax expense Current income taxes U.S. federal $ 30,985 $ — U.S. state — — Total current income taxes $ 30,985 $ — June 30, 2020 2019 Deferred income taxes U.S. federal $ — $ — U.S. state — — Total deferred income tax benefit $ — $ — The following table sets forth reconciliations of the income tax expense at the statutory federal income tax rate to actual expense based on income or loss before income taxes: June 30, 2020 2019 Income tax expense attributable to: Federal $ (3,255,706 ) $ (2,509,246 ) State, net of federal benefit (862,690 ) (13,452 ) Foreign tax rate less than federal rate (2,645 ) — Permanent differences 312,525 — Restricted stock awards — 816,505 Changes in valuation allowance 3,884,440 85,455 Provision to return adjustment (45,134 ) — Losses from flow-through entity not subject to tax — 1,640,066 Other adjustments 195 (19,328 ) Effective income tax expense $ 30,985 $ — June 30, 2020 2019 Noncurrent deferred tax assets: Employee compensation $ 378,003 $ — Debt issuance costs 323,183 — Revenue recognition 156,022 22,226 Federal and state net operating loss 4,082,297 63,229 Foreign net operating loss 258,083 — Total deferred tax assets $ 5,197,588 $ 85,455 Noncurrent deferred tax liabilities: Fixed assets (653,819) — Intangibles (1,808,960) — Deferred tax liabilities $ (2,462,779) $ — Valuation allowance (2,734,809 ) (85,455 ) Deferred taxes after valuation allowance $ — $ — During the year ended June 30, 2020, valuation allowances on deferred tax assets that are not anticipated to be realized increased by $2,649,354. Our deferred tax valuation allowances are primarily the result of uncertainties regarding the future realization of recorded tax benefits on tax losses. The measurement of deferred tax assets is reduced by a valuation allowance if based upon available evidence, it is more likely than not that the deferred tax assets will not be realized. We have evaluated the realizability of our deferred tax assets in each jurisdiction by assessing the adequacy of expected taxable income, including the reversal of existing temporary differences, historical and projected operating results, and the availability of prudent and feasible tax planning strategies. Based on this analysis, we have determined that the valuation allowances recorded as of June 30, 2020 and 2019 are appropriate. We have deferred tax assets related to U.S. federal tax and state tax carryforwards for net operating losses, which will not expire in the amount of $15,286,374. The U.S. federal net operating loss carryforwards do not expire and the U.S. state net operating loss carryforwards expire at various dates beginning in 2039. We have deferred tax assets related to foreign net operating loss carryforward, which begin to expire in 2028, in the amount of $973,900. We are not currently under examination for any of the major jurisdictions where we conduct business as of June 30, 2020, however, all of our tax years remain subject to examination. Our management does not believe there are significant uncertain tax positions in 2020 and as a result we do not expect any cash payments in the next 12 months, however, an uncertain tax position related to potential penalties in the amount of $50,000 has been recorded in connection with one of the business combinations during the year ended June 30, 2020. There are no interest related to uncertain tax positions in 2020.

Equity Method Investment and Re

Equity Method Investment and Related Party Transaction	3 Months Ended
	Sep. 30, 2020
Equity Method Investments and Joint Ventures [Abstract]
Equity Method Investment and Related Party Transaction	Note 7 – Equity Method Investment and Related Party Transactions Investment in and License Agreement with Zol Solutions, Inc. We hold an investment in 203,000 shares of preferred stock of Zol Solutions, Inc., or ZolTrain. In connection with the investment, we received the right to appoint one of three members of ZolTrain's board of directors and the Akerna board member may only be removed from the ZolTrain board by us and we retain the right to fill the vacancy. The ZolTrain preferred stock is convertible into shares of common stock of ZolTrain at a conversion rate of $1.232 per share at our option and contains certain anti-dilution protection in the event of certain future issuances of securities by ZolTrain. We are entitled to vote the number of common shares in which the ZolTrain preferred stock is convertible into at any meeting of the ZolTrain stockholders. The investment also provides us with rights of first refusal with respect to newly issued securities of ZolTrain as well as issued and outstanding securities of ZolTrain that are offered to third parties. We have determined that ZolTrain is a VIE for accounting purposes. However, we are not required to consolidate ZolTrain in our financial statements because we are not ZolTrain's primary beneficiary. As of September 30, 2020, our maximum exposure to loss was equal to the carrying value of our initial investment of $250,000. We have concluded that the ZolTrain Preferred is in substance common stock because the liquidation preference provided is not substantive, as such, the equity method of accounting is applicable to in substance common stock. As a result of our representation on the board of directors, we determined that we can exert significant influence over the day to day operations of ZolTrain therefore; we account for this investment using the equity method of accounting, which requires we recognize our share of the ZolTrain operations in our results of operations. For the three months ended September 30, 2020 we have recognized equity in loss of investee of $1,535, which represents our share of ZolTrain's losses since our investment. Subsequent to our investment, we entered into a nonexclusive license/reseller agreement with ZolTrain, effective October 24, 2019, to provide ZolTrain's online cannabis training platform as a co-branded integration option into our MJ Platform and Leaf Data Systems, which is a related party transaction. ZolTrain will share subscription-based revenue generated from our customers with us. The amount of the share of the revenue for each of us and ZolTrain will depend on both (a) the number of training modules accessed by a customer and (b) which party created the accessed content. In addition to the revenue sharing arrangement, the license/reseller agreement provides us with the right to receive additional consideration from ZolTrain in the form of an equity earnout if certain revenue milestones are achieved during 2020, 2021, and 2022. Our ability to recognize revenue from the additional earnout consideration in the future will mainly depend on whether it becomes probable that such revenue milestones will be achieved. For the three months ended September 30, 2020 we have not recognized any revenue from this agreement. Employment of Scott Sozio In July 2019, we hired Mr. Scott Sozio, at will, to serve as our Head of Corporate Development. Mr. Sozio receives an annual base salary of $150,000, which is to be credited against certain variable bonus compensation to be paid in a combination of cash and equity pursuant to the Incentive Plan once every twelve-month period. The terms of such bonus payment include the payment of 1% of the transaction value of acquisition transactions completed by Akerna, payable one-half as cash compensation and one-half in restricted stock units of Akerna. In April 2020, Mr. Sozio was granted 1,230 restricted stock units of the Akerna under our 2019 Equity Incentive Plan in relation to the closing of our acquisition of Trellis, which vested immediately. In August of 2020, Mr. Sozio's compensation was restructured and he was granted 92,166 restricted stock units, which vest one quarter each year beginning on July 1, 2021. In September 2020, Mr. Sozio was granted 10,000 restricted stock units as part of our annual employee grants, which vest one quarter each year beginning on July 1, 2021 and 38,527 restricted stock units in connection with the closing of our acquisition of Ample, which vested immediately. Additionally, Mr. Sozio received a cash bonus of $225,000 in connection with the Ample acquisition. TechMagic Software Development Services During the three months ended September 30, 2020, our wholly-owned subsidiary Solo was invoiced by TechMagic USA LLC, a Massachusetts limited liability, or TechMagic, for an amount of $291,000. When we acquired Solo in January 2020, we recognized a preacquisition liability of payable to TechMagic of $265,000. Following our acquisition and for the remainder of our fiscal year ended June 30, 2020, we received invoices totaling an aggregate additional amount of $392,000. The invoices set forth services that TechMagic purports to have provided to Solo regarding development of mobile software applications for MJF and Solo between March and September 2020. Mr. Ashesh Shah, our Chief Technology Officer from the date of the Solo acquisition through June 30, 2020, formerly the president of Solo and as of September 30, 2020, a minority holder of common stock, to our knowledge, the founder and one of the principal managers of TechMagic. The invoices state that the services were rendered pursuant to the terms of an agreement regarding the development of mobile software products for Solo, entered into between Solo and TechMagic at a time when Mr. Shah was a principal at both entities. As of September 30, 2020, a $553,000 payable to TechMagic was included in accounts payable and accrued liabilities on our condensed consolidated balance sheet.

Subsequent Events

Subsequent Events	3 Months Ended
	Sep. 30, 2020
Subsequent Events [Abstract]
Subsequent Events	Note 8 - Subsequent Events Issuance of Common Stock On October 30, 2020, we issued 5,000,000 shares of Akerna common stock in a public offering for net proceeds after offering costs of approximately $11.0 million dollars. MagicTech Lawsuit On December 4, 2020, TechMagic USA LLC filed suit against our wholly-owned subsidiary, Solo, in Massachusetts Superior Court, Department Business Litigation, seeking recovery of up to approximately $1.07 million for unpaid invoices pursuant to a Master Services Agreement dated February 5, 2018 by and between TechMagic and Solo. Convertible Debt Waivers On December 23, 2020, we entered into waivers with all the holders of the outstanding senior secured convertible notes, pursuant to which we and the holders, separately and not jointly, agreed to waive certain terms and conditions of the convertible notes as follows: ● The holders irrevocably waived the last sentence of Section 8(a) of the notes requiring that all installment amounts payable under the notes prior to April 1, 2021 be paid in cash pursuant to installment redemptions. We may now elect, in its sole discretion, to pay installment amounts under the notes prior to April 1, 2021, by issuing shares of common stock pursuant to installment conversions or by paying cash pursuant to installment redemptions, in each case in accordance with the existing terms of the notes. ● We irrevocably waived the prohibition on acceleration of installment amounts in Section 8(e) of the notes solely in relation to the installment amount for January 4, 2021, to permit the holders to accelerate the January 4, 2021 installment amount, in whole or in part, to one or more acceleration dates from December 24, 2020 through to and including January 4, 2021, as elected by each holder pursuant to Section 8(e) of the notes. ● We and the holders agreed that we may irrevocably waive the installment scheduled principal amount for any installment date by setting forth in the installment notice for that installment date an installment amount greater than the installment scheduled principal amount due and payable on the next installment date. Each holder may then consent to all or a portion of such increased installment amount for such installment date by written confirmation no later than 4:00 p.m. New York time on the trading day immediately prior to such installment date. Any increased amount for an installment amount above the installment scheduled principal amount for such installment date will reduce the principal amount under the notes. ● In relation to the January 4, 2021 installment amount, we delivered installment notices to the holders increasing the installment amount for January 4, 2021, in the aggregate, by $2,062,500. Lease Settlement On January 7, 2021, we issued 101,705 shares of common stock to a private party in exchange for the termination of a long-term lease agreement.

Revisions of Previously Issued

Revisions of Previously Issued Financial Statements	3 Months Ended	12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Revisions of Previously Issued Financial Statements	Note 9 – Revisions of Previously Issued Financial Statements During the course of preparing the annual report on Form 10-K for the year ended June 30, 2020, we determined that costs incurred during the application development phase of certain new software applications and enhancements were not properly capitalized, which resulted in the overstatement of operating expenses and net loss, and an understatement of amortization expense for each of the quarters during the year ended June 30, 2020. We assessed the materiality of these errors on prior periods' financial statements and concluded that the errors were not material to any prior annual or interim periods, but the cumulative adjustments necessary to correct the errors would be material if we recorded the corrections the period in which the errors were identified. In accordance with GAAP, we are revising the prior periods' financial statements when they are next issued. See Item. 4 of Part I, Controls, and Procedures. The tables below disclose the effects on the financial statements included in this Quarterly Report on Form 10-Q and the financial statements yet to be reissued: Three Months Ended September 30, 2019 As reported Adjustment As revised Condensed Consolidated Statements of Operations Cost of revenue $ 1,397,361 $ (17,660 ) $ 1,379,701 Gross profit 1,795,529 17,660 1,813,189 Product development 1,130,880 (519,978 ) 610,902 Selling, general and administrative 3,583,815 17,899 3,601,714 Net loss (2,846,071 ) 519,739 (2,326,332 ) Net loss per share (0.26 ) — (0.21 ) Three Months Ended December 31, 2019 As reported Adjustment As revised Condensed Consolidated Statements of Operations Cost of revenue $ 1,638,840 $ (23,601 ) $ 1,615,239 Gross profit 1,667,363 23,601 1,690,964 Product development 1,261,509 (638,008 ) 623,501 Selling, general and administrative 4,796,404 86,768 4,883,172 Net loss (4,338,536 ) 574,841 (3,763,695 ) Net loss per share (0.40 ) — (0.34 ) Six Months Ended December 31, 2019 As reported Adjustment As revised Condensed Consolidated Statements of Operations Cost of revenue $ 3,036,201 $ (41,261 ) $ 2,994,940 Gross profit 3,462,892 41,261 3,504,153 Product development 2,392,389 (1,157,986 ) 1,234,403 Selling, general and administrative 8,380,219 104,667 8,484,886 Net loss (7,184,607 ) 1,094,580 (6,090,027 ) Net loss per share (0.66 ) — (0.56 ) Three Months Ended March 31, 2020 As reported Adjustment As revised Condensed Consolidated Statement of Operations Cost of revenue $ 1,420,909 $ (24,690 ) $ 1,396,219 Gross profit 1,649,637 24,690 1,674,327 Product development 1,632,353 (757,566 ) 874,787 Selling, general and administrative 5,500,837 177,405 5,678,242 Net loss (5,348,980 ) 604,851 (4,744,129 ) Net loss per share (0.43 ) — (0.38 ) Nine Months Ended March 31, 2020 As reported Adjustment As revised Condensed Consolidated Statements of Operations Cost of revenue $ 4,457,110 $ (65,951 ) $ 4,391,159 Gross profit 5,112,529 65,951 5,178,480 Product development 4,024,742 (1,915,552 ) 2,109,190 Selling, general and administrative 13,881,056 282,072 14,163,128 Net loss (12,533,587 ) 1,699,431 (10,834,156 ) Net loss per share (1.11 ) — (0.96 )	Note 14 – Revisions of Financial Statements for the Fiscal Quarters during Fiscal Year 2020 During the course of preparing the annual report on Form 10-K for the year ended June 30, 2020, we determined that costs incurred during the application development phase of certain new software applications and enhancements were not properly capitalized, which resulted in the overstatement of operating expenses and net loss, and an understatement of amortization expense for each of the quarters during the year ended June 30, 2020. We assessed the materiality of these errors on prior periods' financial statements and concluded that the errors were not material to any prior annual or interim periods, but the cumulative adjustments necessary to correct the errors would be material if we recorded the corrections the period in which the errors were identified. In accordance with GAAP, we are revising the prior periods' financial statements when they are next issued. See Item. 4 of Part I, Controls, and Procedures. Three Months Ended As reported Adjustment As revised Condensed Consolidated Statements of Operations Cost of revenue $ 1,397,361 $ (17,660 ) $ 1,379,701 Gross profit 1,795,529 17,660 1,813,189 Product development 1,130,880 (519,978 ) 610,902 Selling, general and administrative 3,583,815 17,899 3,601,714 Net loss (2,846,071 ) 519,739 (2,326,332 ) Net loss per share (0.26 ) (0.21 ) Three Months Ended As reported Adjustment As revised Condensed Consolidated Statements of Operations Cost of revenue 1,638,840 (23,601 ) 1,615,239 Gross profit 1,667,363 23,601 1,690,964 Product development 1,261,509 (638,008 ) 623,501 Selling, general and administrative 4,796,404 86,768 4,883,172 Net loss (4,338,536 ) 574,841 (3,763,695 ) Net loss per share (0.40 ) (0.34 ) Six Months Ended As reported Adjustment As revised Condensed Consolidated Statements of Operations Cost of revenue 3,036,201 (41,261) 2,994,940 Gross profit 3,462,892 41,261 3,504,153 Product development 2,392,389 (1,157,986) 1,234,403 Selling, general and administrative 8,380,219 104,667 8,484,886 Net loss (7,184,607 ) 1,094,580 (6,090,027 ) Net loss per share (0.66 ) (0.56 ) Three Months Ended As reported Adjustment As revised Condensed Consolidated Statement of Operations Cost of revenue 1,420,909 (24,690 ) 1,396,219 Gross profit 1,649,637 24,690 1,674,327 Product development 1,632,353 (757,566 ) 874,787 Selling, general and administrative 5,500,837 177,405 5,678,242 Net loss (5,348,980 ) 604,851 (4,744,129 ) Net loss per share (0.43 ) (0.38 ) Nine Months Ended As reported Adjustment As revised Condensed Consolidated Statements of Operations Cost of revenue 4,457,110 (65,951 ) 4,391,159 Gross profit 5,112,529 65,951 5,178,480 Product development 4,024,742 (1,915,552 ) 2,109,190 Selling, general and administrative 13,881,056 282,072 14,163,128 Net loss (12,533,587 ) 1,699,431 (10,834,156 ) Net loss per share (1.11 ) (0.96 )

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended	12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020
Accounting Policies [Abstract]
Basis of presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. Certain footnotes and other financial information normally required by accounting principles generally accepted in the United States of America, or GAAP, have been condensed or omitted in accordance with such rules and regulations. In management's opinion, these condensed consolidated financial statements have been prepared on the same basis as our annual consolidated financial statements and notes thereto and include all adjustments, consisting of normal recurring items, considered necessary for the fair presentation. The operating results for the three months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the fiscal year transition period comprised of six months ending December 31,2020. The condensed consolidated balance sheet for the year ended June 30, 2020, has been derived from our audited financial statements at that date but does not include all disclosures and financial information required by GAAP for complete financial statements. The information included in this quarterly report on Form 10-Q should be read in conjunction with our consolidated financial statements and notes thereto for the year ended June 30, 2020, which were included in our annual report on Form 10-K filed on September 29, 2020.	Basis of Presentation The accompanying financial statements and related notes reflect the historical results of MJF prior to the mergers completed in June 2019, or the Mergers, with MTech Acquisition Corp., or MTech, and other related entities, which resulted in the combined company and do not include the historical results of MTech prior to the completion of the Mergers. The consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States, or GAAP, and our reporting currency is the United States Dollar.
Principles of Consolidation	Principles of Consolidation Our accompanying condensed consolidated financial statements include the accounts of Akerna, our wholly owned subsidiaries and those entities in which we otherwise have a controlling financial interest. All significant intercompany balances and transactions have been eliminated in consolidation. We evaluate our ownership interests, contractual rights and other interests in entities to determine if the entities are variable interest entities, or VIEs, when we have a variable interest in those entities. Generally, a VIE is a legal entity in which the equity investors do not have the characteristics of a controlling financial interest or the equity investors lack sufficient equity at risk for the entity to finance its activities without additional subordinated financial support. These evaluations can be complex and involve judgment and the use of estimates and assumptions based on available historical information. If we determine that we hold a variable interest in a VIE and we are the primary beneficiary of the VIE, we must consolidate the VIE in our financial statements. In determining whether we are the primary beneficiary of a VIE, we consider qualitative and quantitative factors, including, but not limited to: which activities most significantly impact the VIE's economic performance and which party controls such activities; the amount and characteristics of our investment; the obligation or likelihood for us or other investors to provide financial support; and the similarity with and significance to our business activities and the business activities of the other investors. Significant judgments related to these determinations include estimates about the current and future fair values and performance of these VIE's operations and general market conditions. We determine whether we are the primary beneficiary of a VIE upon our initial involvement with the VIE and reassess our status on an ongoing basis.	Principles of Consolidation Our accompanying consolidated financial statements include the accounts of Akerna, our wholly-owned subsidiaries, and those entities in which we otherwise have a controlling financial interest. All significant intercompany balances and transactions have been eliminated in consolidation. We evaluate our ownership interests, contractual rights, and other interests in entities to determine if the entities are variable interest entities or VIEs when we have a variable interest in those entities. Generally, a VIE is a legal entity in which the equity investors do not have the characteristics of a controlling financial interest or the equity investors lack sufficient equity at risk for the entity to finance its activities without additional subordinated financial support. These evaluations can be complex and involve judgment and the use of estimates and assumptions based on available historical information. If we determine that we hold a variable interest in a VIE and we are the primary beneficiary of the VIE, we must consolidate the VIE in our financial statements. In determining whether we are the primary beneficiary of a VIE, we consider qualitative and quantitative factors, including, but not limited to: which activities most significantly impact the VIE's economic performance and which party controls such activities; the amount and characteristics of our investment; the obligation or likelihood for us or other investors to provide financial support; and the similarity with and significance to our business activities and the business activities of the other investors. Significant judgments related to these determinations include estimates about the current and future fair values and performance of these VIE's operations and general market conditions. We determine whether we are the primary beneficiary of a VIE upon our initial involvement with the VIE and reassess our status on an ongoing basis.
Segment Reporting	Segment Reporting Our chief operating decision maker reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance and information for different revenue streams is not evaluated separately. As such, the Company has one operating segment, and the decision-making group is the senior executive management team. In the following table, revenue is disaggregated by primary geographical markets and revenue source. For the Three Months Ended 2020 2019 Primary geographical markets: United States $ 2,285,211 $ 3,054,670 Canada 1,270,109 28,385 Other 158,684 109,835 Total $ 3,714,004 $ 3,192,890 As of As of Long-lived assets: United States $ 10,170,265 $ 10,254,374 Canada 5,345,092 - Total $ 15,515,357 $ 10,254,374	Segments Our chief operating decision maker reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance and information for different revenue streams is not evaluated separately. As such, we have a single operating segment.
Use of estimates	Use of Estimates The preparation of our condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts included in the financial statements and accompanying notes thereto. Actual results could differ materially from those estimates.	Use of Estimates The preparation of our consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts included in the financial statements and accompanying notes thereto. We base our estimates on assumptions that we believe to be reasonable under the circumstances, the results of which form a basis for making judgments about the carrying value of assets and liabilities that are not readily available from other sources. Actual results could differ from those estimates under different assumptions or conditions; however, we believe that our estimates are reasonable.
Cash and cash equivalents		Cash and Cash Equivalents We consider liquid instruments purchased with an original maturity of three months or less to be cash equivalents. There were no cash equivalents as of June 30, 2020 and 2019. We continually monitor our positions with, and the credit quality of, the financial institutions with which we invest. As of the balance sheet date, and periodically throughout the year, we have maintained balances in various operating accounts in excess of federally insured limits. As of June 30, 2020, approximately $23.5 million of our cash balances were uninsured. We have not experienced any losses on such accounts.
Restricted Cash		Restricted Cash Restricted cash consists of funds that are contractually or legally restricted as to usage or withdrawal and is presented separately from cash and cash equivalents on our consolidated balance sheets. Our restricted cash serves as collateral for a letter of credit.
Accounts Receivable, Net	Accounts Receivable, Net We maintain an allowance for doubtful accounts equal to the estimated uncollectible amounts based on our historical collection experience and review of the current status of trade accounts receivable. The allowance for doubtful accounts was $0.2 million as September 30, 2020 and $0.2 million as of June 30, 2020.	Accounts Receivable, Net We maintain an allowance for doubtful accounts equal to the estimated uncollectible amounts based on our historical collection experience and review of the current status of trade accounts receivable. Receivables are written-off and charged against the recorded allowance when we have exhausted collection efforts without success. The allowance for doubtful accounts was $0.2 million as of June 30, 2020, and 2019. The allowance for doubtful accounts consists of the following activity for the years ended June 30, 2020 and 2019: 2020 2019 Allowance for doubtful accounts, beginning balance $ 190,088 $ 39,571 Additions: Bad debt expense 1,094,507 345,941 Deductions: Write-off uncollectable accounts (1,076,173 ) (195,424 ) Allowance for doubtful accounts, ending balance $ 208,422 $ 190,088
Concentrations of Credit Risk	Concentrations of Credit Risk We grant credit in the normal course of business to customers in the United States. We periodically perform credit analysis and monitor the financial condition of our customers to reduce credit risk. During the three months ended September 30, 2020, and 2019, one government client accounted for 17 % and 24% of total revenues, respectively. As of September 30, 2020,	Concentrations of Credit Risk We grant credit in the normal course of business to customers in the United States. We periodically perform credit analysis and monitor the financial condition of our customers to reduce credit risk. During the year ended June 30, 2020 and 2019, government client accounted for % and 30% of total revenues, respectively. As of June 30, 2020, and 2019 government clients accounted for a total of 36% and 18%, and 34% and 24% of net accounts receivable, respectively.
Equity Method Investments		Equity Method Investments We make strategic investments in privately held equity securities of companies that provide technology solutions that are complementary to ours. When we can exert significant influence over, but do not control, the investee's operations, through voting rights or representation on the investee's board of directors, we account for the investment using the equity method of accounting. We record our share in the investee's earnings and losses in the consolidated statement of operations. We assess our investment for other-than-temporary impairment when events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable and recognize an impairment loss to adjust the investment to its then-current fair value.
Intangible Assets Acquired through Business Combinations		Intangible Assets Acquired through Business Combinations Intangible assets are amortized over their estimated useful lives. We evaluate the estimated remaining useful life of our intangible assets when events or changes in circumstances indicate an adjustment to the remaining amortization may be needed. We similarly evaluate the recoverability of these assets upon events or changes in circumstances indicate a potential impairment. Recoverability of these assets is measured by comparing the carrying amount of each asset to the future undiscounted cash flows the asset is expected to generate. If the undiscounted cash flows used in the test for recoverability are less than the carrying amount of these assets, the carrying amount of such assets is reduced to fair value. There were no impairments of intangible assets during the year ended June 30, 2020, or 2019.
Goodwill Impairment Assessment	Goodwill Impairment Assessment We evaluate and test the recoverability of our goodwill for impairment at least annually during October of each year or more often if circumstances indicate that goodwill may not be recoverable. To date, we have not recorded any impairment of our goodwill.	Goodwill Impairment Assessment We evaluate and test the recoverability of our goodwill for impairment at least annually during October of each year or more often if circumstances indicate that goodwill may not be recoverable.
Foreign Currency Translation	Foreign Currency Translation We have Canadian operations with Canadian Dollar as the functional currency. Foreign exchange gains and losses and translation adjustments, which result from the process of remeasuring foreign currency transactions into the appropriate functional currency, were immaterial during the quarter ended September 30, 2020.
Software Development Costs		Software Development Costs Costs incurred during the application development stage of a newly developed application and costs we incur to enhance our existing platforms that meet certain criteria are subject to capitalization and subsequent amortization. Product development stage costs were approximately $3.2 million during the year ended June 30, 2020. Product development costs are primarily comprised of personnel costs such as payroll and benefits, vendor costs, and other costs directly attributable to the project. We capitalize costs only during the development phase. Any costs in connection to planning, design, and maintenance subsequent to release are expensed as incurred. We amortize software development costs over the expected useful life of the specific application, generally 2-5 years. We evaluate capitalized software development costs for impairment when there is an indication that the unamortized cost may not be recoverable.
Fair Value of Financial Instruments		Fair Value of Financial Instruments GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Under this guidance, we are required to classify certain assets and liabilities based on the fair value hierarchy, which groups fair value-measured assets and liabilities based upon the following levels of inputs: ● Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; ● Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; ● Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity). The fair value of financial instruments is the amount at which the instrument could be exchanged in a current transaction between willing parties. The carrying values of financial instruments such as accounts receivable accounts payable and accrued liabilities approximate fair value based on their short maturities. Please refer to Note 11 - Fair Value Measurements for additional information regarding the fair value of financial instruments that we measure at fair value, including senior secured convertible notes and contingent consideration.
Fair Value Option		Fair Value Option The fair value option provides an election that allows a company to irrevocably elect to record certain financial assets and liabilities at fair value on an instrument-by-instrument basis at initial recognition. We have elected to apply the fair value option to certain convertible notes due to the complexity of the various conversion and settlement options available to both the Note Holders and Akerna. The convertible notes accounted for under the fair value option election are each a debt host financial instrument containing embedded features that would otherwise be required to be bifurcated from the debt-host and recognized as separate derivative liabilities subject to initial and subsequent periodic estimated fair value measurements in accordance with GAAP. Notwithstanding, When the fair value option election is applied to financial liabilities, bifurcation of an embedded derivative is no required, and the financial liability is initially measured at its issue-date estimated fair value and then subsequently remeasured at estimated fair value on a recurring basis as of each reporting period date. The portion of the change in fair value attributed to a change in the instrument-specific credit risk is recognized as a component of other comprehensive income and the remaining amount of the fair value adjustment is recognized as other income (expense) in our consolidated statement of operations. The estimated fair value adjustment is presented in a respective single line item within other income (expense) in the accompanying consolidated statement of operations because the change in fair value of the convertible notes was not attributable to instrument-specific credit risk.
Revenue Recognition		Revenue Recognition We derive our revenues primarily from the following sources: software revenues, which are primarily comprised of subscription fees from government and commercial customers accessing our enterprise cloud computing services and from customers paying for additional support beyond the standard support that is included in the basic subscription fees; and consulting services provided to operators interested in integrating our platform into their respective operations, such services include: assessing compliance requirements, monitoring systems and readiness; assisting with the application process; and evaluating the operator's inspection readiness and business plan. We commence revenue recognition when there is persuasive evidence of an arrangement, the service has been or is being provided to the customer, the collection of the fees is reasonably assured, and the amount of fees to be paid by the customer is fixed or determinable. Software Revenue Software revenue primarily consists of subscription revenue that is recognized ratably over the term of the contract, beginning when access to the applicable software is provided to the customer. We typically invoice customers at the beginning of the term, in multi-year, annual, quarterly, or monthly installments. When a collection of fees occurs in advance of service delivery, revenue recognition is deferred until such services commence. Revenue for implementation fees is recognized ratably over the expected term of the contract, including expected renewals. We include service level commitments to customers warranting certain levels of uptime reliability and performance and permitting those customers to receive credits if those levels are not met. In addition, customer contracts often include: specific obligations that require us to maintain the availability of the customer's data through the service and that customer content is secured against unauthorized access or loss, and indemnity provisions whereby we indemnify customers from third-party claims asserted against them that result from our failure to maintain the availability of their content or securing the same from unauthorized access or loss. To date, we have not incurred any material costs as a result of such commitments. Any such credits or payments made to customers under these arrangements are recorded as a reduction of revenue. Consulting Services Revenue Consulting services revenue consists of contracts with fixed terms and fee structures based upon the volume and activity or fixed-price contracts for consulting and strategic services. When these services are not combined with subscription revenues as a single unit of account, as discussed below, these revenues are recognized as services are rendered and accepted by the customer. Other Revenues We sell solo*TAG ™ ™ ™ ™ Cost of Revenue Cost of revenue consists primarily of costs related to providing subscription and other services to our customers, including employee compensation and related expenses for data center operations, customer support and professional services personnel, payments to outside technology service providers, security services, and other tools. Deferred Revenue Deferred revenue consists of payments received in advance of revenue recognition from subscription services. The deferred revenue balance is influenced by several factors, including seasonality, the compounding effects of renewals, contract duration, and invoice frequency. Deferred revenue that will be recognized during the succeeding twelve-month period is recorded as deferred revenue, which is a current liability on the accompanying consolidated balance sheets.
Supplemental Information Regarding Noncash Investing and Financing Activities	Supplemental Information Regarding Noncash Investing and Financing Activities During the three months ended September 30, 2020, we acquired 100% of the outstanding equity interest in Ample Organics, Inc., or Ample, in exchange for Akerna common stock valued at $25.2 million, please refer to Note 3 for additional information about the transaction and a schedule of the assets acquired and liabilities assumed in conjunction with this transaction
Reclassifications and Revisions	Reclassifications and Revisions Certain prior year financial statement amounts have been reclassified for consistency with the current year presentation. Additionally, certain prior year financial statement amounts have been revised to correct misstatements in the prior year, please refer to Note 9 for additional information regarding the corrections.	Reclassifications Certain prior year financial statement amounts have been reclassified for consistency with the current year presentation.
Income Taxes		Income Taxes Income taxes are accounted for using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of other assets and liabilities. We provide for income taxes at the current and future enacted tax rates and laws applicable in each taxing jurisdiction. We use a two-step approach for recognizing and measuring tax benefits taken or expected to be taken in a tax return and disclosures regarding uncertainties in income tax positions. We recognize interest and penalties related to income tax matters in selling, general and administrative expenses in the consolidated statement of operations. We recognize deferred tax assets to the extent that its assets are more likely than not to be realized. In making such a determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, and results of recent operations. If we determine that we would be able to realize our deferred tax assets in the future in excess of its net recorded amount, we will make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.
Stock-Based Compensation	Stock-Based Compensation We measured stock-based compensation based on the fair value of the share-based awards on the date of grant and recognize the related costs on a straight-line basis over the requisite service period, which is generally the vesting period. During the three months ended September 30, 2020, we granted 451,925 shares of Restricted Stock Units at an aggregate grant date fair value of approximately $2.2 million, vesting equally over four years.	Stock-Based Compensation We measured stock-based compensation based on the fair value of the share-based awards on the date of grant and recognize the related costs on a straight-line basis over the requisite service period, which is generally the vesting period.
Recently Issued Accounting Pronouncements	Recent Accounting Pronouncements The Financial Accounting Standards Board, or the FASB, has issued guidance to simplify the remeasurement of goodwill when impairment is identified. Under existing guidance we would have to perform procedures to determine the fair value of our assets and liabilities as of the testing date in a manner similar to the procedures necessary to allocate purchase price to acquired assets and liabilities in a business combination. Under the new guidance, the goodwill impairment charge is equal to the excess of the carrying value of the reporting unit to which goodwill is assigned and the fair value of that reporting unit. We have elected to adopt the guidance early effective July 1, 2020 and will utilize this approach if necessary when we perform our annual goodwill impairment test. The FASB has issued guidance related to the accounting for share-based compensation to nonemployees, which eliminates the separate accounting model for nonemployee share-based payment awards and generally requires companies to account for share-based payment transactions with nonemployees in the same way as share-based payment transactions with employees. Under the new guidance, nonemployee share-based payment transactions are measured at the grant-date fair value and are no longer remeasured at the then-current fair values at each reporting date until the share options have vested. The amended guidance is effective for our fiscal year end transition financial statements for the six months ending December 31, 2020 and for interim periods beginning on January 1, 2021. We have completed our implementation procedures and concluded that there will be no material impact to our results of operations or financial condition as a result of this new standard. The FASB has issued guidance to revise accounting for revenue from contracts with customers, which supersedes the revenue recognition requirements and industry-specific guidance currently in effect for us. The new revenue standard requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. The new revenue standard is effective for our fiscal 2021 annual reporting period and for interim periods thereafter. The new revenue standard allows for either full retrospective or modified retrospective adoption. We will adopt the new standard using the modified retrospective approach and anticipate that the timing of recognition of incremental costs of obtaining contracts will be the most significant change to our results of operations upon adoption. As a result of our announced change in fiscal year end to December 31, 2020, as further discussed in Note 1, we will adopt the new standard in our transition period financial statements for the six months ending December 31, 2020. We are in the process of finalizing our implementation of this standard and expect to record a cumulative catch up adjustment to defer certain direct contract costs that have previously been recognized as expense as incurred, Additionally, we expect to adjust the recognition pattern for certain implementation fees earned in connection with government contracts. The FASB has issued new guidance related to the accounting for leases. The new standard establishes a right-of-use model that requires a lessee to record a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the statement of operations. Following our change in fiscal year effective on December 31, 2020, the new standard is effective for us beginning with our fiscal year ending December 31, 2022 and in interim periods thereafter. We have limited assets subject to operating lease and therefore expect the adoption of the new standard to result in the recognition of right of use assets and lease liabilities for any office or vehicle leases in effect at that date, we do not expect a significant impact to our results of operations. The FASB has issued guidance to introduce a new model for recognizing credit losses on financial instruments based on estimated current expected credit losses, or CECL. Under the new standard, an entity is required to estimate CECL on trade receivables at inception, based on historical information, current conditions, and reasonable and supportable forecasts. Following our change in fiscal year-end effective December 31, 2020, the new guidance is effective for us beginning on January 1, 2023. We are evaluating the impact of adoption of the new standard on our consolidated financial statements. The FASB has issued guidance regarding whether internal-use software development costs should be capitalized or charged to expense. Depending upon on the nature of the costs and the project stage in which they are incurred. Capitalized development costs are subject to amortization and impairment guidance consistent with existing internal-use software development cost guidance. Following our change in fiscal year end effective December 31, 2020, the guidance is applicable for us for the year ending December 31, 2021 and in interim periods thereafter, with early adoption permitted, including adoption in an interim period. We are evaluating the impact of adoption of the new standard on our financial statements. The FASB has issued guidance clarifying the interactions between various standards governing investments in equity securities. The new guidance addresses accounting for the transition into and out of the equity method and measurement of certain purchased options and forward contracts to acquire investments. The standard is effective for us for annual and interim periods beginning on January 1, 2022, with early adoption permitted. Adoption of the standard requires changes to be made prospectively. We do not anticipate a significant impact to our financial statements as a result of this new guidance.	Recently Issued Accounting Pronouncements The Financial Accounting Standards Board, or the FASB, has issued guidance to revise accounting for revenue from contracts with customers, which supersedes the revenue recognition requirements and industry-specific guidance currently in effect for us. The new revenue standard requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. The new revenue standard is effective for our fiscal 2021 annual reporting period and for interim periods thereafter. The new revenue standard allows for either full retrospective or modified retrospective adoption. We will adopt the new standard using the modified retrospective approach and anticipate that the timing of recognition of incremental costs of obtaining contracts will be the most significant change to our results of operations upon adoption. The FASB has issued new guidance related to the accounting for leases. The new standard establishes a right-of-use model that requires a lessee to record a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the statement of operations. The new standard is effective for us in our fiscal year beginning in 2022. We are evaluating the impact of the adoption of the new standard on our consolidated financial statements and do not anticipate a significant impact on our results of operations. The FASB has issued guidance to introduce a new model for recognizing credit losses on financial instruments based on estimated current expected credit losses, or CECL. Under the new standard, an entity is required to estimate CECL on trade receivables at inception, based on historical information, current conditions, and reasonable and supportable forecasts. The new guidance is effective for us in our fiscal year beginning in 2023. We are evaluating the impact of the adoption of the new standard on our consolidated financial statements. The FASB has issued guidance related to the accounting for share-based compensation to nonemployees, which eliminates the separate accounting model for nonemployee share-based payment awards and generally requires companies to account for share-based payment transactions with nonemployees in the same way as share-based payment transactions with employees. Under the new guidance, nonemployee share-based payment transactions are measured at the grant-date fair value and are no longer remeasured at the then-current fair values at each reporting date until the share options have vested. The amended guidance is effective for our annual financial statements for the fiscal year beginning on July 1, 2020, and for interim periods beginning in the subsequent fiscal year. We do not anticipate the adoption of this guidance to have a significant effect on our results of operations. The FASB has issued guidance regarding when internal-use software development costs should be capitalized or charged to expense. Depending upon the nature of the costs and the project stage in which they are incurred. Capitalized development costs are subject to amortization and impairment guidance consistent with existing internal-use software development cost guidance. The guidance is applicable for us in our fiscal year beginning in 2023 with early adoption permitted, including adoption in an interim period. We are evaluating the impact of the adoption of the new standard on our financial statements. The FASB has issued guidance clarifying the interactions between various standards governing investments in equity securities. The new guidance addresses accounting for the transition into and out of the equity method and measurement of certain purchased options and forward contracts to acquire investments. The standard is effective for us for annual and interim periods in our fiscal year beginning in 2022, with early adoption permitted. Adoption of the standard requires changes to be made prospectively. We are evaluating the impact of adoption of the new standard on our consolidated financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended	12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020
Accounting Policies [Abstract]
Schedule of allowance for doubtful accounts		2020 2019 Allowance for doubtful accounts, beginning balance $ 190,088 $ 39,571 Additions: Bad debt expense 1,094,507 345,941 Deductions: Write-off uncollectable accounts (1,076,173 ) (195,424 ) Allowance for doubtful accounts, ending balance $ 208,422 $ 190,088
Schedule of disaggregated by primary geographical markets and revenue	For the Three Months Ended 2020 2019 Primary geographical markets: United States $ 2,285,211 $ 3,054,670 Canada 1,270,109 28,385 Other 158,684 109,835 Total $ 3,714,004 $ 3,192,890 As of As of Long-lived assets: United States $ 10,170,265 $ 10,254,374 Canada 5,345,092 - Total $ 15,515,357 $ 10,254,374

Significant Transactions (Table

Significant Transactions (Tables)	3 Months Ended	12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020
Business Acquisition [Line Items]
Schedule of acquisition date fair value of consideration	Preliminary Common shares issued $ 25,203 Cash 5,724 Contingent consideration 817 Total preliminary fair value of consideration transferred $ 31,744
Schedule of fair values of assets acquired and liabilities	Preliminary Cash $ 445 Accounts receivable 917 Prepaid expenses 149 Intangible assets and goodwill 30,433 Furniture, fixtures and equipment 1,327 Accounts payable and accrued expenses (978 ) Deferred revenue (549 ) Net assets acquired $ 31,744
Schedule of financial information combined results of operations	Three Months Ended 2020 2019 Revenues $ 3,790 $ 4,130 Net loss $ (4,686 ) $ (4,185 )	June 30, 2020 2019 Revenues $ 13,584 $ 12,220 Net loss (20,589 ) (15,884 )
Solo Sciences, Inc. [Member]
Business Acquisition [Line Items]
Schedule of estimated acquisition date fair value of consideration		Common shares issued $ 17,550 Contingent consideration 389 Total estimated fair value of consideration $ 17,939
Schedule of fair values of assets acquired and liabilities		Cash $ 101 Prepaid expenses and other assets 22 Furniture, fixtures, and equipment 2 Acquired technology 7,160 Acquired trade name 340 Goodwill 17,025 Accounts payable and accrued liabilities (1,158 ) Fair value of noncontrolling interests (5,554 ) Net assets acquired $ 17,938
Trellis Solutions, Inc [Member]
Business Acquisition [Line Items]
Schedule of estimated acquisition date fair value of consideration		Common shares issued $ 2,531 Contingent consideration 998 Total estimated fair value of consideration $ 3,529
Schedule of fair values of assets acquired and liabilities		Cash $ 21 Accounts receivable, net 77 Other assets 6 Acquired technology 210 Acquired trade name 80 Customer relationships 220 Goodwill 3,229 Accounts payable and accrued expenses (283 ) Deferred revenue (31 ) Net assets acquired $ 3,529

Fair Value (Tables)

Fair Value (Tables)	3 Months Ended	12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020
Fair Value Disclosures [Abstract]
Schedule of reconciliation of fair values	Fair value balance as of June 30, 2020 $ 14,131,000 Change in fair value reported in the statements of operations (778,000 ) Change in fair value reported in other comprehensive income 70,000 Fair value balance as of September 30, 2020 $ 13,423,000	Beginning fair value balance on issue date - June 9, 2020 $ 14,960,000 Change in fair value reported in the statements of operations (766,000 ) Change in fair value reported in other comprehensive income (63,000 ) Ending fair value balance - June 30, 2020 $ 14,131,000
Schedule of fair value by using key inputs	Fair Value Assumptions - Convertible Notes September 30, June 30, Face value principal payable $ 17,000,000 $ 17,000,000 Original conversion price $ 11.50 $ 11.50 Value of Common Stock $ 3.64 $ 8.80 Expected term (years) 2.67 2.90 Volatility 68 % 45 % Market yield 28.0 % 23.9 % Risk free rate 0.1% to 0.2 % 0.2 %	Fair Value Assumptions - Convertible Notes June 30, June 9, Face value principal payable $ 17,000,000 $ 17,000,000 Original conversion price $ 11.50 $ 11.50 Value of Common Stock $ 8.80 $ 10.28 Expected term (years) 2.9 3.0 Volatility 45.0 % 45.0 % Market yield (range) 23.9 % 23.3% to 23.4 Risk free rate 0.2 % 0.2 %

Balance Sheet Disclosures (Tabl

Balance Sheet Disclosures (Tables)	12 Months Ended
	Jun. 30, 2020
Balance Sheet Disclosures [Abstract]
Schedule of prepaid expenses	2020 2019 Software and technology $ 571,695 $ 237,930 Professional services, dues, and subscriptions 473,731 169,804 Insurance 105,814 159,940 Rental deposit 38,303 10,000 Other 25,798 — Total Prepaid Expenses and Other Current Assets $ 1,215,341 $ 577,674
Schedule of Accrued liabilities	2020 2019 Accounts payable $ 1,443,895 $ 1,317,566 Professional fees 2,273,659 49,205 Sales taxes 59,825 36,358 Compensation 260,042 354,724 Contractors 782,366 19,557 Other 42,141 40,706 Total accounts payable and accrued liabilities $ 4,861,928 $ 1,818,116

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets, Net (Tables)	12 Months Ended
	Jun. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of changes in the carrying amount of goodwill	Balance as of June 30, 2019 $ — Additions due to acquisitions 20,254,309 Balance as of June 30, 2020 $ 20,254,309
Schedule of intangible assets	Weighted average remaining amortization period (in years) Gross carrying amount Accumulated amortization Net Acquired developed technology 4.42 $ 7,370,000 $ (679,696 ) $ 6,690,304 Acquired trade names 7.40 420,000 (23,248 ) 396,752 Customer relationships 1.75 220,000 (24,475 ) 195,525 Other intangible assets, not yet placed into service N/A 211,394 — 211,394 Intangible assets $ 8,221,394 $ (727,419 ) $ 7,493,975 Capitalized software - In-service 1.86 2,852,044 (560,528 ) 2,291,516 Capitalized software - Work in Progress N/A 337,788 — 337,788 Total Capitalized Software 3,189,832 (560,528 ) 2,629,304 Total finite-lived intangible assets $ 11,411,226 $ (1,287,947 ) $ 10,123,279
Schedule of capitalized software and purchased intangible assets	Acquired Intangible Assets Capitalized Software 2021 $ 1,711,444 $ 1,325,851 2022 1,663,607 806,012 2023 1,490,511 63,838 2024 1,469,778 63,838 2025 813,444 31,977 Thereafter 133,797 — Total $ 7,282,581 $ 2,291,516

Long Term Debt (Tables)

Long Term Debt (Tables)	12 Months Ended
	Jun. 30, 2020
Line of Credit Facility [Abstract]
Schedule of long-term debt	Convertible Notes (at fair value) $ 14,131,000 PPP loan 2,204,600 Subtotal 16,335,600 Less: current maturities (6,135,364 ) Total long-term debt, less current portion $ 10,200,236
Schedule of maturities of outstanding long-term debt obligations in subsequent years	Fiscal Year ending June 30, 2021 $ 6,844,620 2022 12,359,980 Aggregate maturities 19,204,600 Original issue discount on Convertible Notes (2,040,000 ) Unrealized change in fair value of Convertible Notes (829,000 ) Long term debt outstanding as of June 30, 2020 $ 16,335,600

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Jun. 30, 2020
Equity [Abstract]
Schedule of common stock warrants	Shares Issuable Under Warrants Weighted-average Exercise Price Weighted Average Remaining Life Aggregate Intrinsic Value Outstanding as of July 1, 2018 5,993,750 $ 11.50 — $ — Issued 189,365 11.50 — — Exercised — — — — Expired/canceled — — — — Outstanding at June 30, 2019 6,183,115 $ 11.50 4.97 $ 2,473,000 Issued — — — — Exercised (369,311 ) — — — Expired/canceled — — — — Outstanding at June 30, 2020 5,813,804 $ 11.50 3.97 $ —

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Jun. 30, 2020
Share-based Payment Arrangement [Abstract]
Schedule of unvested restricted shares and restricted stock units ("RSUs") activity	Restricted Shares Restricted Stock Units Total Weighted Average Grant Date Fair Value Unvested as of June 30, 2019 215,063 — 215,063 $ 11.99 Granted — 571,229 571,229 7.24 Vested (88,659 ) (26,965 ) (115,624 ) 7.25 Forfeited (54,091 ) (78,470 ) (132,561 ) 10.83 Unvested as of June 30, 2020 72,313 465,794 538,107 $ 6.56

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Schedule of future minimum lease payments	Three months ending December 31, 2020 $ 226,687 2021 918,847 2022 439,633 2023 421,418 2024 426,495 2025 464,575 Thereafter 983,731 Total $ 3,881,386

Loss Per Share (Tables)

Loss Per Share (Tables)	3 Months Ended	12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020
Earnings Per Share [Abstract]
Schedule of diluted earnings per share	Three Months Ended 2020 2019 Shares issuable upon exchange of Exchangeable Shares 2,667,349 — Shares of common stock issuable in upon conversion of Convertible Notes 1,542,632 — Warrants 5,813,804 5,814,205 Unvested restricted stock units 824,143 — Unvested restricted stock awards 64,296 215,063 Total 10,912,224 6,029,268	Fully Diluted Weighted Average for the Year Ended 2020 2019 2020 2019 Warrants 5,813,804 6,183,115 5,833,971 6,001,013 Restricted Stock Units 325,121 — 37,709 — Restricted Stock Awards 75,654 215,063 7,656 2,351 Shares of common stock issuable in upon conversion of Convertible Notes 1,936,845 — 111,130 — Total 8,151,424 6,398,178 5,990,466 6,003,364

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Jun. 30, 2020
Income Tax Disclosure [Abstract]
Schedule of expense or (benefit) for income taxes	June 30, 2020 2019 Income tax expense Current income taxes U.S. federal $ 30,985 $ — U.S. state — — Total current income taxes $ 30,985 $ — June 30, 2020 2019 Deferred income taxes U.S. federal $ — $ — U.S. state — — Total deferred income tax benefit $ — $ —
Schedule of statutory federal income tax rate to actual rates based on income or loss before income taxes	June 30, 2020 2019 Income tax expense attributable to: Federal $ (3,255,706 ) $ (2,509,246 ) State, net of federal benefit (862,690 ) (13,452 ) Foreign tax rate less than federal rate (2,645 ) — Permanent differences 312,525 — Restricted stock awards — 816,505 Changes in valuation allowance 3,884,440 85,455 Provision to return adjustment (45,134 ) — Losses from flow-through entity not subject to tax — 1,640,066 Other adjustments 195 (19,328 ) Effective income tax expense $ 30,985 $ —
Schedule of changes in Noncurrent deferred tax assets and liabilities	June 30, 2020 2019 Noncurrent deferred tax assets: Employee compensation $ 378,003 $ — Debt issuance costs 323,183 — Revenue recognition 156,022 22,226 Federal and state net operating loss 4,082,297 63,229 Foreign net operating loss 258,083 — Total deferred tax assets $ 5,197,588 $ 85,455 Noncurrent deferred tax liabilities: Fixed assets (653,819) — Intangibles (1,808,960) — Deferred tax liabilities $ (2,462,779) $ — Valuation allowance (2,734,809 ) (85,455 ) Deferred taxes after valuation allowance $ — $ —

Revisions of Previously Issue_2

Revisions of Previously Issued Financial Statements (Tables)	3 Months Ended	12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of financial statements	Three Months Ended September 30, 2019 As reported Adjustment As revised Condensed Consolidated Statements of Operations Cost of revenue $ 1,397,361 $ (17,660 ) $ 1,379,701 Gross profit 1,795,529 17,660 1,813,189 Product development 1,130,880 (519,978 ) 610,902 Selling, general and administrative 3,583,815 17,899 3,601,714 Net loss (2,846,071 ) 519,739 (2,326,332 ) Net loss per share (0.26 ) — (0.21 ) Three Months Ended December 31, 2019 As reported Adjustment As revised Condensed Consolidated Statements of Operations Cost of revenue $ 1,638,840 $ (23,601 ) $ 1,615,239 Gross profit 1,667,363 23,601 1,690,964 Product development 1,261,509 (638,008 ) 623,501 Selling, general and administrative 4,796,404 86,768 4,883,172 Net loss (4,338,536 ) 574,841 (3,763,695 ) Net loss per share (0.40 ) — (0.34 ) Six Months Ended December 31, 2019 As reported Adjustment As revised Condensed Consolidated Statements of Operations Cost of revenue $ 3,036,201 $ (41,261 ) $ 2,994,940 Gross profit 3,462,892 41,261 3,504,153 Product development 2,392,389 (1,157,986 ) 1,234,403 Selling, general and administrative 8,380,219 104,667 8,484,886 Net loss (7,184,607 ) 1,094,580 (6,090,027 ) Net loss per share (0.66 ) — (0.56 ) Three Months Ended March 31, 2020 As reported Adjustment As revised Condensed Consolidated Statement of Operations Cost of revenue $ 1,420,909 $ (24,690 ) $ 1,396,219 Gross profit 1,649,637 24,690 1,674,327 Product development 1,632,353 (757,566 ) 874,787 Selling, general and administrative 5,500,837 177,405 5,678,242 Net loss (5,348,980 ) 604,851 (4,744,129 ) Net loss per share (0.43 ) — (0.38 ) Nine Months Ended March 31, 2020 As reported Adjustment As revised Condensed Consolidated Statements of Operations Cost of revenue $ 4,457,110 $ (65,951 ) $ 4,391,159 Gross profit 5,112,529 65,951 5,178,480 Product development 4,024,742 (1,915,552 ) 2,109,190 Selling, general and administrative 13,881,056 282,072 14,163,128 Net loss (12,533,587 ) 1,699,431 (10,834,156 ) Net loss per share (1.11 ) — (0.96 )	Three Months Ended As reported Adjustment As revised Condensed Consolidated Statements of Operations Cost of revenue $ 1,397,361 $ (17,660 ) $ 1,379,701 Gross profit 1,795,529 17,660 1,813,189 Product development 1,130,880 (519,978 ) 610,902 Selling, general and administrative 3,583,815 17,899 3,601,714 Net loss (2,846,071 ) 519,739 (2,326,332 ) Net loss per share (0.26 ) (0.21 ) Three Months Ended As reported Adjustment As revised Condensed Consolidated Statements of Operations Cost of revenue 1,638,840 (23,601 ) 1,615,239 Gross profit 1,667,363 23,601 1,690,964 Product development 1,261,509 (638,008 ) 623,501 Selling, general and administrative 4,796,404 86,768 4,883,172 Net loss (4,338,536 ) 574,841 (3,763,695 ) Net loss per share (0.40 ) (0.34 ) Six Months Ended As reported Adjustment As revised Condensed Consolidated Statements of Operations Cost of revenue 3,036,201 (41,261) 2,994,940 Gross profit 3,462,892 41,261 3,504,153 Product development 2,392,389 (1,157,986) 1,234,403 Selling, general and administrative 8,380,219 104,667 8,484,886 Net loss (7,184,607 ) 1,094,580 (6,090,027 ) Net loss per share (0.66 ) (0.56 ) Three Months Ended As reported Adjustment As revised Condensed Consolidated Statement of Operations Cost of revenue 1,420,909 (24,690 ) 1,396,219 Gross profit 1,649,637 24,690 1,674,327 Product development 1,632,353 (757,566 ) 874,787 Selling, general and administrative 5,500,837 177,405 5,678,242 Net loss (5,348,980 ) 604,851 (4,744,129 ) Net loss per share (0.43 ) (0.38 ) Nine Months Ended As reported Adjustment As revised Condensed Consolidated Statements of Operations Cost of revenue 4,457,110 (65,951 ) 4,391,159 Gross profit 5,112,529 65,951 5,178,480 Product development 4,024,742 (1,915,552 ) 2,109,190 Selling, general and administrative 13,881,056 282,072 14,163,128 Net loss (12,533,587 ) 1,699,431 (10,834,156 ) Net loss per share (1.11 ) (0.96 )

Description of Business, Liqu_2

Description of Business, Liquidity and Capital Resources (Details) - USD ($)	1 Months Ended	3 Months Ended		12 Months Ended
	Oct. 30, 2020	Sep. 30, 2020	Sep. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Jun. 08, 2020
Description of Business, Liquidity and Capital Resources (Textual)
Description of liquidity and capital resources		Although we have continuing negative cash flow from operations, the cash outflow since the Mergers is partially attributable to approximately $5.1 million in costs incurred in connection with specific transactions, including the Mergers, acquisitions completed or expected to close within the next twelve months and the issuance of debt. We began a cost reduction initiative in the second half of our fiscal year ended June 30, 2020 and during the three months ended September 30, 2020, we implemented phase two of that initiative. The cost-cutting measures included a reduction in headcount, because as our business has matured we have been able to streamline our operations, we also determined to forego certain costs, which have not historically yielded sufficient returns. Since beginning this initiative we have achieved a reduction in cash used in operations in excess of $0.6 million on a quarterly basis. On October 30, 2020, we closed a public offering of our common stock with net proceeds of $11.9 million after equity issuance costs. We anticipate our current cash balances will be sufficient to meet the working capital requirements for the next twelve months.		Although we have continuing negative cash flow from operations, the cash outflow since the Mergers is partially attributable to approximately $4.1 million in costs incurred in connection with specific transactions, including the Mergers, acquisitions completed or expected to close within the next twelve months and the issuance of debt. We implemented a cost reduction initiative and achieved a reduction in cash used in operations in excess of $1.0 million between the third and fourth quarters of fiscal year 2020.
Net proceeds of secured convertible notes						$ 13,800,000
Net loss		$ (4,741,876)	$ (2,326,332)	$ (15,534,345)	$ (12,403,215)
Cash in operations		(4,181,159)	(3,142,174)	(14,347,652)	(9,048,595)
Working capital		900,000
Non recurring expenses		1,100,000
PPP Loan		$ 2,000,000
Cost reduction initiatives, description		cost reduction initiatives reducing costs and identifying costs savings that we expect to result in annual savings of an additional $3.0 million to $4.0 million.
Loss from operations		$ (5,523,470)	(2,399,427)	(17,271,851)	(12,512,346)
Cash		14,257,858		24,155,828	21,867,289
Offering costs					$ 10,000,000
Subsequent Event [Member]
Description of Business, Liquidity and Capital Resources (Textual)
Common stock, shares	5
Offering costs	$ 11,000,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Primary geographical markets:
Total	$ 3,714,004	$ 3,192,890	$ 12,573,276	$ 10,823,117
Long-lived assets:
Long-Lived assets	15,515,357	10,254,374
United States [Member]
Primary geographical markets:
Total	2,285,211	3,054,670
Long-lived assets:
Long-Lived assets	10,170,265	10,254,374
Canada [Member]
Primary geographical markets:
Total	1,270,109	28,385
Long-lived assets:
Long-Lived assets	5,345,092
Other [Member]
Primary geographical markets:
Total	$ 158,684	$ 109,835

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details 1) - USD ($)	3 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Accounting Policies [Abstract]
Allowance for doubtful accounts, beginning balance	$ 208,422	$ 190,088	$ 190,088	$ 39,571
Additions:
Bad debt expense	$ 12,450	$ 252,809	1,094,507	345,941
Deductions:
Write-off uncollectable accounts			(1,076,173)	(195,424)
Allowance for doubtful accounts, ending balance			$ 208,422	$ 190,088

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Details Textual)	3 Months Ended		12 Months Ended
	Sep. 30, 2020USD ($)CustomersSegmentsshares	Sep. 30, 2019Customers	Jun. 30, 2020USD ($)Customers	Jun. 30, 2019USD ($)Customers
Summary of Significant Accounting Policies (Textual)
Allowance for doubtful accounts | $	$ 200,000		$ 200,000	$ 200,000
Product development stage costs | $			3,200,000
Cash balances | $	14,257,858		$ 24,155,828	21,867,289
Common stock valued | $	$ 25,200,000			$ 18,878,775
Acquired entity ownership acquired	100.00%
Granted shares of restricted stock | shares | shares	451,925
Granted fair value | $	$ 2,200,000
Number of Reportable Segments | Segments	1
Minimum [Member]
Summary of Significant Accounting Policies (Textual)
Expected useful life			2 years
Maximum [Member]
Summary of Significant Accounting Policies (Textual)
Expected useful life			5 years
Total revenues [Member]
Summary of Significant Accounting Policies (Textual)
Number of customer | Customers	1
Net accounts receivable [Member]
Summary of Significant Accounting Policies (Textual)
Concentration risk percentage		63.00%
Customer one [Member] | Total revenues [Member]
Summary of Significant Accounting Policies (Textual)
Concentration risk percentage	17.00%	24.00%	25.00%	30.00%
Number of customer | Customers	1		1	1
Customer one [Member] | Net accounts receivable [Member]
Summary of Significant Accounting Policies (Textual)
Concentration risk percentage			36.00%	34.00%
Number of customer | Customers			2	2
Customer two [Member] | Net accounts receivable [Member]
Summary of Significant Accounting Policies (Textual)
Concentration risk percentage			18.00%	24.00%
Number of customer | Customers			2	2
Two Government Customers [Member]
Summary of Significant Accounting Policies (Textual)
Concentration risk percentage	38.00%	20.00%
Two Government Customers [Member] | Total revenues [Member]
Summary of Significant Accounting Policies (Textual)
Number of customer | Customers	2	2

Significant Transactions (Detai

Significant Transactions (Details) - USD ($)	Apr. 08, 2020	Sep. 30, 2020
Business Acquisition [Line Items]
Common shares issued		$ 25,203
Cash		5,724
Contingent consideration		817
Total preliminary fair value of consideration transferred		$ 31,744
Trellis Solutions, Inc [Member]
Business Acquisition [Line Items]
Common shares issued	$ 2,531
Contingent consideration	998
Total estimated fair value of consideration	$ 3,529

Significant Transactions (Det_2

Significant Transactions (Details 1) - USD ($)	Sep. 30, 2020	Jun. 30, 2020
Business Acquisition [Line Items]
Cash	$ 445
Accounts receivable, net	917
Prepaid expenses	149
Intangible assets and goodwill	30,433
Furniture, fixtures, and equipment	1,327
Accounts payable and accrued expenses	(978)
Deferred revenue	(549)
Net assets acquired	$ 31,744
Trellis Solutions, Inc [Member]
Business Acquisition [Line Items]
Cash		$ 21
Accounts receivable, net		77
Other assets		6
Acquired technology		210
Acquired trade name		80
Customer relationships		220
Goodwill		3,229
Accounts payable and accrued expenses		(283)
Deferred revenue		(31)
Net assets acquired		$ 3,529

Significant Transactions (Det_3

Significant Transactions (Details 2) - USD ($)	Jan. 15, 2020	Sep. 30, 2020
Business Acquisition [Line Items]
Common shares issued		$ 25,203
Solo Sciences, Inc. [Member]
Business Acquisition [Line Items]
Common shares issued	$ 17,550
Contingent consideration	389
Total estimated fair value of consideration	$ 17,939

Significant Transactions (Det_4

Significant Transactions (Details 3) - USD ($)	Sep. 30, 2020	Jun. 30, 2020
Business Acquisition [Line Items]
Cash	$ 445
Prepaid expenses and other assets	149
Furniture, fixtures, and equipment	1,327
Accounts payable and accrued liabilities	(978)
Net assets acquired	$ 31,744
Solo Sciences, Inc. [Member]
Business Acquisition [Line Items]
Cash		$ 101
Prepaid expenses and other assets		22
Furniture, fixtures, and equipment		2
Acquired technology		7,160
Acquired trade name		340
Goodwill		17,025
Accounts payable and accrued liabilities		(1,158)
Fair value of noncontrolling interests		(5,554)
Net assets acquired		$ 17,938

Significant Transactions (Det_5

Significant Transactions (Details 4) - USD ($)	3 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Significant Transactions [Abstract]
Revenues	$ 3,790	$ 4,130	$ 13,584	$ 12,220
Net loss	$ (4,686)	$ (4,185)	$ (20,589)	$ (15,884)

Fair Value (Details)

Fair Value (Details) - USD ($)	3 Months Ended	12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020
Fair Value Disclosures [Abstract]
Fair value balance as of June 30, 2020	$ 14,131,000	$ 14,960,000
Change in fair value reported in the statements of operations	(778,000)	766,000
Change in fair value reported in other comprehensive income	70,000	(63,000)
Fair value balance as of September 30, 2020	$ 13,423,000	$ 14,131,000

Fair Value (Details 1)

Fair Value (Details 1) - USD ($)	Jun. 09, 2020	Sep. 30, 2020	Jun. 30, 2020
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Face value principal payable	$ 17,000,000	$ 17,000,000	$ 17,000,000
Original conversion price	$ 11.50	$ 11.50	$ 11.50
Value of Common Stock	$ 10.28	$ 3.64	$ 8.80
Expected term (years)	3 years	2 years 8 months 1 day	2 years 10 months 24 days
Volatility	45.00%	68.00%	45.00%
Market yield		28.00%	23.90%
Risk free rate	0.20%		0.20%
Minimum [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Market yield	23.30%
Risk free rate		0.10%
Maximum [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Market yield	23.40%
Risk free rate		0.20%

Fair Value (Details Textual)

Fair Value (Details Textual) - USD ($)	Jul. 07, 2020	Jul. 07, 2020	Jan. 15, 2020	Sep. 30, 2020	Jun. 30, 2020	Jun. 09, 2020	Jun. 30, 2019
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Description of contingent consideration	We acquired 100% of the stock of Ample Organics by issuing 3.3 million exchangeable shares of one of our wholly-owned subsidiaries. The exchangeable shares may be exchanged, at the option of the holder, for shares of Akerna common stock on a one-for-one basis, therefore the exchangeable shares issued were valued at $7.65 per share, the closing price of an equivalent share of Akerna common stock, for an aggregate value of $25.2 million. The exchangeable shares are economically equivalent to shares of Akerna common stock. In addition to the stock consideration, we paid $5.7 million in cash, which was used to settle all of Ample's then outstanding debt and transaction costs. The agreement provides for contingent consideration of up to CAD$10,000,000, payable in exchangeable shares, payable if Ample's Recurring Revenue recognized during the 12 months after the acquisition date is CAD$9,000,000 or more. The contingent consideration amount is reduced by an amount equal to the product of CAD$6.67 multiplied by the difference between CAD$9,000,000 and the amount of Recurring Revenue realized during the 12 months following the acquisition. The contingent consideration was recorded as the estimated fair value of $0.8 million as of the acquisition date and will be adjusted to the estimated fair value in each subsequent reporting period until settlement.	We acquired 100% of the stock of Ample Organics for 3.3 million exchangeable shares of one of our wholly-owned subsidiaries. The exchangeable shares may be exchanged, at the option of the holder, for shares of Akerna common stock on a one-for-one basis, therefore the exchangeable shares issued were valued at $7.65 per share, the closing price of an equivalent share of Akerna common stock, $30.7 million was the aggregate value of the exchangeable shares. In addition to the stock consideration, we paid $5.5 million in cash, which was used to settle all of Ample's then outstanding debt. In addition to the stock and cash consideration, the agreement provides for contingent consideration of up to CAD$10,000,000, payable in exchangeable shares, payable if Ample's Recurring Revenue recognized during the 12 months after the acquisition date is CAD$9,000,000 or more. The contingent consideration amount is reduced by an amount equal to the product of CAD$6.67 multiplied by the difference between CAD$9,000,000 and the amount of Recurring Revenue realized during the 12 months following the acquisition. The contingent consideration will be recorded as the estimated fair value on the acquisition date and adjusted to estimated fair value in each subsequent reporting period until settlement.			(i) $0.01 per solo*TAGTM and solo*CODETM sold or (ii) 7% of net revenue. The fees were to be paid annually until the earlier of: (1) our shares trading above $12 per share for any consecutive 20 trading days in a 30-day period; (b) upon our no longer owning a majority stake in Solo; or (c) upon expiration of the patents related to solo*TAGTM and solo*CODETM, which is December 1, 2029.
Principal amount						$ 170
Purchase price						$ 150
Acquisition of ample			$ 389,000	$ 817,000	$ 389,000
Aggregate liability				$ 817,000
Ample [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Description of contingent consideration				The agreement provides for contingent consideration of up to CAD$10,000,000, payable in exchangeable shares, payable if Ample's Recurring Revenue recognized during the 12 months after the acquisition date is CAD$9,000,000 or more. The contingent consideration amount is reduced by an amount equal to the product of CAD$6.67 multiplied by the difference between CAD$9,000,000and the amount of Recurring Revenue realized during the twelve months following the acquisition.
Acquisition of ample				$ 817,000
Solo Sciences, Inc. [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Description of contingent consideration			(i) $0.01 per solo*TAG™ and solo*CODE™ sold or (ii) 7% of net revenue. The fees were to be paid annually until the earlier of: (1) our shares trading above $12 per share for any consecutive 20 trading days in a 30-day period; (b) upon our no longer owning a majority stake in Solo; or (c) upon expiration of the patents related to solo*TAG™ and solo*CODE™, which is December 1, 2029. This fee represents contingent consideration and was recorded at fair value as of the date of acquisition. Contingent consideration is adjusted to fair value each period with changes in fair value being recognized in earnings at each reporting period.	(i) $0.01 per solo*TAGTM and solo*CODETM sold or (ii) 7% of net revenue. The fees were to be paid annually until the earlier of: (1) our shares trading above $12 per share for any consecutive 20 trading days in a 30-day period; (b) upon our no longer owning a majority stake in Solo; or (c) upon expiration of the patents related to solo*TAGTM and solo*CODETM, which is December 1, 2029.
Fair value of the contingent consideration				$ 0	389,000
Liability for the contingent consideration					389,000
Trellis Solutions, Inc [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value of the contingent consideration					998,000
Liability for the contingent consideration					$ 0

Significant Transactions (Det_6

Significant Transactions (Details Textual) - USD ($)	Jul. 07, 2020	Jul. 07, 2020	Apr. 08, 2020	Jan. 15, 2020	Jan. 15, 2020	Jul. 31, 2020	Jun. 17, 2019	Sep. 30, 2020	Jun. 30, 2020	Sep. 30, 2019	Jun. 30, 2020	Jun. 30, 2020	Jun. 30, 2019	Jan. 07, 2021	Sep. 01, 2020	Jul. 31, 2019
Significant Transactions (Textual)
Bussiness combination interst																1.00%
Selling general and administrative expenses								$ 1,000
Contingent consideration, description	We acquired 100% of the stock of Ample Organics for 3.3 million exchangeable shares of one of our wholly-owned subsidiaries. The exchangeable shares may be exchanged, at the option of the holder, for shares of Akerna common stock on a one-for-one basis, therefore the exchangeable shares issued were valued at $7.65 per share, the closing price of an equivalent share of Akerna common stock, $30.7 million was the aggregate value of the exchangeable shares. In addition to the stock consideration, we paid $5.5 million in cash, which was used to settle all of Ample's then outstanding debt. In addition to the stock and cash consideration, the agreement provides for contingent consideration of up to CAD$10,000,000, payable in exchangeable shares, payable if Ample's Recurring Revenue recognized during the 12 months after the acquisition date is CAD$9,000,000 or more. The contingent consideration amount is reduced by an amount equal to the product of CAD$6.67 multiplied by the difference between CAD$9,000,000 and the amount of Recurring Revenue realized during the 12 months following the acquisition. The contingent consideration will be recorded as the estimated fair value on the acquisition date and adjusted to estimated fair value in each subsequent reporting period until settlement.	We acquired 100% of the stock of Ample Organics by issuing 3.3 million exchangeable shares of one of our wholly-owned subsidiaries. The exchangeable shares may be exchanged, at the option of the holder, for shares of Akerna common stock on a one-for-one basis, therefore the exchangeable shares issued were valued at $7.65 per share, the closing price of an equivalent share of Akerna common stock, for an aggregate value of $25.2 million. The exchangeable shares are economically equivalent to shares of Akerna common stock. In addition to the stock consideration, we paid $5.7 million in cash, which was used to settle all of Ample's then outstanding debt and transaction costs. The agreement provides for contingent consideration of up to CAD$10,000,000, payable in exchangeable shares, payable if Ample's Recurring Revenue recognized during the 12 months after the acquisition date is CAD$9,000,000 or more. The contingent consideration amount is reduced by an amount equal to the product of CAD$6.67 multiplied by the difference between CAD$9,000,000 and the amount of Recurring Revenue realized during the 12 months following the acquisition. The contingent consideration was recorded as the estimated fair value of $0.8 million as of the acquisition date and will be adjusted to the estimated fair value in each subsequent reporting period until settlement.										(i) $0.01 per solo*TAGTM and solo*CODETM sold or (ii) 7% of net revenue. The fees were to be paid annually until the earlier of: (1) our shares trading above $12 per share for any consecutive 20 trading days in a 30-day period; (b) upon our no longer owning a majority stake in Solo; or (c) upon expiration of the patents related to solo*TAGTM and solo*CODETM, which is December 1, 2029.
Net income/loss from business combinations								$ 40
Shareholders exchanged								627,225
Exchangeable shares value								$ 479,827,100
Voting preferred stock, par value								$ 0.0001
Common stock, shares						800,000	6,520,099	14,685,932	13,258,707		13,258,707	13,258,707	10,589,746	101,705	2,667,349
Common stock, shares outstanding								14,685,932	13,258,707		13,258,707	13,258,707	10,589,746		2,667,349
Preferred stock liquidation, description								special voting preferred stock has a par value of $0.0001 per share and a preference in liquidation of $1.00.
Shares of common stock per share							$ 10.16
Percentage of exchange rate																1.00%
Gain on change fair value of contingent consideration												$ 1,000,000
Description of contingent consideration	We acquired 100% of the stock of Ample Organics for 3.3 million exchangeable shares of one of our wholly-owned subsidiaries. The exchangeable shares may be exchanged, at the option of the holder, for shares of Akerna common stock on a one-for-one basis, therefore the exchangeable shares issued were valued at $7.65 per share, the closing price of an equivalent share of Akerna common stock, $30.7 million was the aggregate value of the exchangeable shares. In addition to the stock consideration, we paid $5.5 million in cash, which was used to settle all of Ample's then outstanding debt. In addition to the stock and cash consideration, the agreement provides for contingent consideration of up to CAD$10,000,000, payable in exchangeable shares, payable if Ample's Recurring Revenue recognized during the 12 months after the acquisition date is CAD$9,000,000 or more. The contingent consideration amount is reduced by an amount equal to the product of CAD$6.67 multiplied by the difference between CAD$9,000,000 and the amount of Recurring Revenue realized during the 12 months following the acquisition. The contingent consideration will be recorded as the estimated fair value on the acquisition date and adjusted to estimated fair value in each subsequent reporting period until settlement.	We acquired 100% of the stock of Ample Organics by issuing 3.3 million exchangeable shares of one of our wholly-owned subsidiaries. The exchangeable shares may be exchanged, at the option of the holder, for shares of Akerna common stock on a one-for-one basis, therefore the exchangeable shares issued were valued at $7.65 per share, the closing price of an equivalent share of Akerna common stock, for an aggregate value of $25.2 million. The exchangeable shares are economically equivalent to shares of Akerna common stock. In addition to the stock consideration, we paid $5.7 million in cash, which was used to settle all of Ample's then outstanding debt and transaction costs. The agreement provides for contingent consideration of up to CAD$10,000,000, payable in exchangeable shares, payable if Ample's Recurring Revenue recognized during the 12 months after the acquisition date is CAD$9,000,000 or more. The contingent consideration amount is reduced by an amount equal to the product of CAD$6.67 multiplied by the difference between CAD$9,000,000 and the amount of Recurring Revenue realized during the 12 months following the acquisition. The contingent consideration was recorded as the estimated fair value of $0.8 million as of the acquisition date and will be adjusted to the estimated fair value in each subsequent reporting period until settlement.										(i) $0.01 per solo*TAGTM and solo*CODETM sold or (ii) 7% of net revenue. The fees were to be paid annually until the earlier of: (1) our shares trading above $12 per share for any consecutive 20 trading days in a 30-day period; (b) upon our no longer owning a majority stake in Solo; or (c) upon expiration of the patents related to solo*TAGTM and solo*CODETM, which is December 1, 2029.
Estimated of fair value contingent consideration												$ 0
Revenues								$ 3,714,004		$ 3,192,890		12,573,276	$ 10,823,117
Net loss								$ (4,741,876)		$ (2,326,332)		$ (15,534,345)	$ (12,403,215)
Common stock vested shares							283,010
Unvested restricted stock							215,063
Description of Merger agreement							(a) 283,110 fully vested shares of common stock were allocated to the former holders of MJF profit interest units, resulting in the recognition of approximately $3.4 million on June 17, 2019 and approximately $2.1 million of compensation expense related to unvested restricted shares such profit interest units be recognized over the remaining vesting period of 3 years.
Description of noncontrolling interests						We entered into an amendment to the stock purchase agreement to exercise our option to acquire the noncontrolling interests in Solo, for 800,000 shares of our common stock, this transaction will be recorded as an equity transaction, with no effect to the value of the assets acquired or liabilities assumed.
Solo Sciences, Inc. [Member]
Significant Transactions (Textual)
Bussiness combination interst				80.40%	80.40%
Fair value of consideration transfered					$ 17,939
Contingent consideration, description				(i) $0.01 per solo*TAG™ and solo*CODE™ sold or (ii) 7% of net revenue. The fees were to be paid annually until the earlier of: (1) our shares trading above $12 per share for any consecutive 20 trading days in a 30-day period; (b) upon our no longer owning a majority stake in Solo; or (c) upon expiration of the patents related to solo*TAG™ and solo*CODE™, which is December 1, 2029. This fee represents contingent consideration and was recorded at fair value as of the date of acquisition. Contingent consideration is adjusted to fair value each period with changes in fair value being recognized in earnings at each reporting period.				(i) $0.01 per solo*TAGTM and solo*CODETM sold or (ii) 7% of net revenue. The fees were to be paid annually until the earlier of: (1) our shares trading above $12 per share for any consecutive 20 trading days in a 30-day period; (b) upon our no longer owning a majority stake in Solo; or (c) upon expiration of the patents related to solo*TAGTM and solo*CODETM, which is December 1, 2029.
Common stock, shares				1,950,000	1,950,000
Transaction costs				$ 300,000	$ 300,000
Shares of common stock per share				$ 9	$ 9
Percentage of exchange rate				80.40%	80.40%
Description of contingent consideration				(i) $0.01 per solo*TAG™ and solo*CODE™ sold or (ii) 7% of net revenue. The fees were to be paid annually until the earlier of: (1) our shares trading above $12 per share for any consecutive 20 trading days in a 30-day period; (b) upon our no longer owning a majority stake in Solo; or (c) upon expiration of the patents related to solo*TAG™ and solo*CODE™, which is December 1, 2029. This fee represents contingent consideration and was recorded at fair value as of the date of acquisition. Contingent consideration is adjusted to fair value each period with changes in fair value being recognized in earnings at each reporting period.				(i) $0.01 per solo*TAGTM and solo*CODETM sold or (ii) 7% of net revenue. The fees were to be paid annually until the earlier of: (1) our shares trading above $12 per share for any consecutive 20 trading days in a 30-day period; (b) upon our no longer owning a majority stake in Solo; or (c) upon expiration of the patents related to solo*TAGTM and solo*CODETM, which is December 1, 2029.
Estimated of fair value contingent consideration				$ 17,900,000
Revenues											$ 23,000
Net loss											$ 1,471,000
Trellis Solutions, Inc [Member]
Significant Transactions (Textual)
Bussiness combination interst			100.00%
Fair value of consideration transfered			$ 3,529
Common stock, shares			349,650
Transaction costs			$ 100,000
Shares of common stock per share			$ 7.24
Percentage of exchange rate			100.00%
Revenues									$ 216,000
Net loss									$ 17,000

Balance Sheet Disclosures (Deta

Balance Sheet Disclosures (Details) - USD ($)	Jun. 30, 2020	Jun. 30, 2019
Balance Sheet Disclosures [Abstract]
Software and technology	$ 571,695	$ 237,930
Professional services, dues, and subscriptions	473,731	169,804
Insurance	105,814	159,940
Rental deposit	38,303	10,000
Other	25,798
Total Prepaid Expenses and Other Current Assets	$ 1,215,341	$ 577,674

Balance Sheet Disclosures (De_2

Balance Sheet Disclosures (Details 1) - USD ($)	Jun. 30, 2020	Jun. 30, 2019
Balance Sheet Disclosures [Abstract]
Accounts payable	$ 1,443,895	$ 1,317,566
Professional fees	2,273,659	49,205
Sales taxes	59,825	36,358
Compensation	260,042	354,724
Contractors	782,366	19,557
Other	42,141	40,706
Total accounts payable and accrued liabilities	$ 4,861,928	$ 1,818,116

Balance Sheet Disclosures (De_3

Balance Sheet Disclosures (Details Textual) - USD ($)	Jun. 30, 2020	Jun. 30, 2019
Balance Sheet Disclosures (Textual)
Accrued compensation	$ 128,000	$ 215,000

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets, Net (Details)	12 Months Ended
	Jun. 30, 2020USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Balance at beginning of year
Additions due to acquisitions	20,254,309
Balance at end of year	$ 20,254,309

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets, Net (Details 1)	12 Months Ended
	Jun. 30, 2020USD ($)
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 8,221,394
Accumulated amortization	(727,419)
Net carrying amount	$ 7,493,975
Acquired trade names [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted average remaining amortization period (in years)	7 years 4 months 24 days
Gross carrying amount	$ 420,000
Accumulated amortization	(23,248)
Net carrying amount	$ 396,752
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted average remaining amortization period (in years)	1 year 9 months
Gross carrying amount	$ 220,000
Accumulated amortization	(24,475)
Net carrying amount	$ 195,525
Acquired developed technology [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted average remaining amortization period (in years)	4 years 5 months 1 day
Gross carrying amount	$ 7,370,000
Accumulated amortization	(679,696)
Net carrying amount	$ 6,690,304
Capitalized software - In-service [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted average remaining amortization period (in years)	1 year 10 months 10 days
Net carrying amount	$ 2,291,516
Total Capitalized Software [Member]
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	3,189,832
Accumulated amortization	(560,528)
Net carrying amount	2,629,304
Capitalized Software Work In Progress [Member]
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	337,788
Accumulated amortization
Net carrying amount	337,788
Other intangible assets, not yet placed into service
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	211,394
Accumulated amortization
Net carrying amount	211,394
Total finite-lived intangible assets [Member]
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	11,411,226
Accumulated amortization	(1,287,947)
Net carrying amount	$ 10,123,279

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets, Net (Details 2)	Jun. 30, 2020USD ($)
Finite-Lived Intangible Assets [Line Items]
Total	$ 7,493,975
Acquired Intangible Assets [Member]
Finite-Lived Intangible Assets [Line Items]
2021	1,711,444
2022	1,663,607
2023	1,490,511
2024	1,469,778
2025	813,444
Thereafter	133,797
Total	7,282,581
Capitalized Software [Member]
Finite-Lived Intangible Assets [Line Items]
2021	1,325,851
2022	806,012
2023	63,838
2024	63,838
2025	31,977
Thereafter
Total	$ 2,291,516

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets, Net (Details Textual)	12 Months Ended
	Jun. 30, 2020USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense of intangible assets	$ 1,300,000

Long Term Debt (Details)

Long Term Debt (Details) - USD ($)	Sep. 30, 2020	Jun. 30, 2020	Jun. 30, 2019
Line of Credit Facility [Abstract]
Convertible Notes (at fair value)		$ 14,131,000
PPP loan		2,204,600
Subtotal		16,335,600
Less: current maturities		(6,135,364)
Total long-term debt, less current portion	$ 5,481,599	$ 10,200,236

Long Term Debt (Details 1)

Long Term Debt (Details 1)	Jun. 30, 2020USD ($)
Line of Credit Facility [Abstract]
2021	$ 6,844,620
2022	12,359,980
Aggregate maturities	19,204,600
Original issue discount on Convertible Notes	(2,040,000)
Unrealized change in fair value of Convertible Notes	(829,000)
Long term debt outstanding as of June 30, 2020	$ 16,335,600

Long Term Debt (Details Textual

Long Term Debt (Details Textuals) - USD ($)	Jun. 09, 2020	Jun. 08, 2020	Apr. 30, 2020	Jun. 30, 2020
Long Term Debt (Textual)
Default interest rate		15.00%
Principal portion of convertible debt	$ 1,000
Original issue discount percentage		12.00%
Convertible notes on issuance amount				$ 15,000,000
Conversion price percentage				80.00%
Conversion price				$ 11.50
Original issue discount on holders	$ 880
Face value of the notes		$ 1,700,000
Description of loan			The PPP Loan, from a lender in the aggregate amount of $2.2 million pursuant to the Paycheck Protection Program under the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act. The PPP Loan is evidenced by a promissory note dated April 21, 2020, the Note. The PPP Loan bears interest at a fixed rate of 1.0% per annum, with the first six months of interest deferred from the date of the Note, has an initial term of two years from the date of the Note, and is unsecured and guaranteed by the Small Business Administration. We may prepay up to 20% of the PPP Loan amount at any time prior to maturity with no prepayment penalties. We must pay all accrued interest if we prepay greater than 20% of the PPP Loan amount and the PPP Loan has been sold on the secondary market. The Note provides for customary events of default. The PPP Loan may be accelerated upon the occurrence of an event of default. The PPP Loan may be forgiven in accordance with the terms of the CARES Act. The principal amount of the PPP Loan not forgiven and accrued interest is to be repaid in 18 equal monthly installments beginning seven months from the date of the disbursement of the PPP Loan. We applied for the PPP Loan and received the proceeds from the PPP Loan prior to the issuance of the recent guidance from the United States Treasury Department and U.S. Small Business Administration on April 23, 2020. We are currently evaluating the impact this guidance has on Akerna and the PPP Loan.
Conversion price floor				1.92
Convertible Debt [Member]
Long Term Debt (Textual)
Conversion price				$ 11.50
Description of loan				The fair value of the Convertible Notes on issuance was recorded as $15.0 million. During the year ended June 30, 2020, the fair value of the Convertible Notes decreased by $0.8 million. Of the adjustment, a decrease of $0.1 million resulted from instrument-specific credit risk and was recognized as other comprehensive income and accumulated in equity and a decrease of $0.8 million was recognized as current period other expense in our consolidated statement of operations. As of June 30, 2020, the fair value of the Convertible Notes on our consolidated balance sheet was $14.1 million.

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($)	12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Shares Issuable Under Warrants
Beginning balance, outstanding	6,183,115	5,993,750
Issued		189,365
Exercised	(369,311)
Expired/canceled
Ending balance, outstanding	5,813,804	6,183,115
Weighted-average Exercise Price
Beginning balance, outstanding	$ 11.50	$ 11.50
Issued		11.50
Exercised
Expired/canceled
Ending balance, outstanding	$ 11.50	$ 11.50
Weighted Average Remaining Life
Beginning balance, outstanding	4 years 11 months 19 days
Ending balance, outstanding	3 years 11 months 19 days	4 years 11 months 19 days
Aggregate Intrinsic Value
Ending balance, outstanding	$ 2,473,000

Stockholders' Equity (Details T

Stockholders' Equity (Details Textual) - USD ($)	12 Months Ended
	Jun. 30, 2020	Sep. 30, 2020	Jun. 30, 2019
Stockholders' Equity (Textual)
Common stock, shares authorized	75,000,000	75,000,000	75,000,000
Common stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	4,999,999	5,000,000
Preferred stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Sale of stock, description	We sold 5,750,000 units at a purchase price of $10.00 per unit, inclusive of 750,000 units sold to the underwriters on February 8, 2018, upon the underwriters' election to fully exercise their over-allotment option. Each unit consisted of one share of MTech's common stock and one warrant ("Public Warrant"). Each Public Warrant entitled the holder to purchase one share of MTech's common stock at an exercise price of $11.50. Upon the Mergers, the Public Warrants were converted to those of Akerna at the exchange ratio of one-for-one.
Proceeds from mergers	$ 18,000,000
Merger related expense	$ 4,400,000
Private Placement Shares [Member]
Stockholders' Equity (Textual)
Issue of Class A common stock	901,074
Aggregate purchase price	$ 9,200,000

Stock-Based Compensation (Detai

Stock-Based Compensation (Details)	12 Months Ended
	Jun. 30, 2020$ / sharesshares
Restricted Shares
Beginning balance, Nonvested	215,063
Granted
Vested	(88,659)
Forfeited	(54,091)
Ending balance, Nonvested	72,313
Restricted Stock Units
Beginning balance
Granted	571,229
Vested	(26,965)
Forfeited	(78,470)
Ending balance	(465,794)
Total
Beginning balance	215,063
Granted	571,229
Vested	(115,624)
Forfeited	(132,561)
Ending balance	538,107
Weighted Average Grant Date Fair Value
Beginning balance | $ / shares	$ 11.99
Granted | $ / shares	7.24
Vested | $ / shares	7.25
Forfeited | $ / shares	10.83
Ending balance | $ / shares	$ 6.56

Stock-Based Compensation (Det_2

Stock-Based Compensation (Details Textual) - USD ($)	1 Months Ended	12 Months Ended
	Jun. 26, 2020	Jun. 30, 2020	Jun. 17, 2019
Stock-Based Compensation (Textual)
One-time charge		$ 3,400,000
Stock based compensation costs as software development cost		100,000
Unrecognized costs		3,900,000
Equity Incentive Plan [Member]
Stock-Based Compensation (Textual)
Common stock reserved			1,040,038
Equity Incentive Plan [Member] | Minimum [Member]
Stock-Based Compensation (Textual)
Shares authorized for issuance	525,000
Equity Incentive Plan [Member] | Maximum [Member]
Stock-Based Compensation (Textual)
Shares authorized for issuance	1,565,038
Restricted Stock [Member]
Stock-Based Compensation (Textual)
Stock-based compensation expenses related to unvested Restricted Shares and RSUs		$ 1,300,000
Estimated remaining vesting period		3 years 1 month 6 days

Loss Per Share (Details)

Loss Per Share (Details) - shares	3 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Class of Stock [Line Items]
Outstanding shares on fully diluted	10,912,224	6,029,268	8,151,424	6,398,178
Outstanding shares on weighted average			5,990,466	6,003,364
Shares of common stock issuable in upon conversion of Convertible Notes [Member]
Class of Stock [Line Items]
Outstanding shares on fully diluted	1,542,632		1,936,845
Outstanding shares on weighted average			111,130
Shares issuable upon exchange of Exchangeable Shares [Member]
Class of Stock [Line Items]
Outstanding shares on fully diluted	2,667,349
Warrants [Member]
Class of Stock [Line Items]
Outstanding shares on fully diluted	5,813,804	5,814,205	5,813,804	6,183,115
Outstanding shares on weighted average			5,833,971	6,001,013
Unvested restricted stock units [Member]
Class of Stock [Line Items]
Outstanding shares on fully diluted	824,143		325,121
Outstanding shares on weighted average			37,709
Unvested restricted stock awards [Member]
Class of Stock [Line Items]
Outstanding shares on fully diluted	64,296	215,063	75,654	215,063
Outstanding shares on weighted average			7,656	2,351

Commitments and Contingencies_2

Commitments and Contingencies (Details) - USD ($)	Sep. 30, 2020	Jun. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Three months ending December 31, 2020	$ 226,687
2021	918,847	$ 526,185
2022	439,633	$ 305,214
2023	421,418
2024	426,495
2025	464,575
Thereafter	983,731
Total	$ 3,881,386

Commitments and Contingencies_3

Commitments and Contingencies (Details Textual) - USD ($)	3 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Rent expense	$ 273,000	$ 36,000	$ 299,629	$ 151,458
Future minimum lease payments two years	439,633		305,214
Future minimum lease payments next 12 months	918,847		526,185
Restricted cash	$ 500,000		500,000	500,000
Line of Credit [Member]
Restricted cash			500,000	$ 500,000
Letter-of-credit with a bank			$ 500,000

Equity Method Investment and _2

Equity Method Investment and Related Party Transaction (Details) - USD ($)	Oct. 07, 2019	Aug. 30, 2020	Apr. 30, 2020	Jul. 31, 2019	Sep. 30, 2020	Jun. 30, 2020	Jun. 09, 2020
Equity Method Investment and Related Party Transaction (Textual)
Restricted stock granted units					38,527
Cash bonus					$ 5,724
Face amount					$ 17,000,000	$ 17,000,000	$ 17,000,000
Mr. Scott Sozio [Member]
Equity Method Investment and Related Party Transaction (Textual)
Annual salary				$ 150,000
Acquisition percentage				1.00%
Restricted stock granted units		92,166	1,230		10,000
Cash bonus			$ 225,000
TechMagic USA LLC [Member]
Equity Method Investment and Related Party Transaction (Textual)
Face amount					$ 291,000
Payable to related party					265,000
Additional amount						$ 392,000
Accounts payable and accrued liabilities					553,000
Subsidiaries [Member]
Equity Method Investment and Related Party Transaction (Textual)
Convertible into shares of common stock per share	$ 1.232
Preferred stock purchased shares	203,000
Preferred stock purchased share value	$ 250,000
Carrying value of our initial investment					250,000
Equity loss of investee					$ 1,535

Income Taxes (Details 1)

Income Taxes (Details 1) - USD ($)	12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Current income taxes
U.S. federal	$ 30,985
U.S. state
Total current income taxes	30,985
Deferred income taxes
U.S. federal
U.S. state
Total deferred income tax benefit

Income Taxes (Details 2)

Income Taxes (Details 2) - USD ($)	12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Income tax expense attributable to:
Federal	$ (3,255,706)	$ (2,509,246)
State, net of federal benefit	(862,690)	(13,452)
Foreign tax rate less than federal rate	(2,645)
Permanent differences	312,525
Restricted stock awards		816,505
Changes in valuation allowance	3,884,440	85,455
Provision to return adjustment	(45,134)
Losses from flow-through entity not subject to tax		1,640,066
Other adjustments	195	(19,328)
Effective income tax expense	$ 30,985

Income Taxes (Details 3)

Income Taxes (Details 3) - USD ($)	Jun. 30, 2020	Jun. 30, 2019
Noncurrent deferred tax assets:
Employee compensation	$ 378,003
Debt issuance costs	323,183
Revenue recognition	156,022	22,226
Federal and state net operating loss	4,082,297	63,229
Foreign net operating loss	258,083
Total deferred tax assets	5,197,588	85,455
Noncurrent deferred tax liabilities:
Fixed assets	(653,819)
Intangibles	(1,808,960)
Deferred tax liabilities	(2,462,779)
Valuation allowance	(2,734,809)	(85,455)
Deferred taxes after valuation allowance

Income Taxes (Details Textual)

Income Taxes (Details Textual)	12 Months Ended
	Jun. 30, 2020USD ($)
Income Tax Disclosure [Abstract]
Net operating losses	$ 15,286,374
Change in valuation allowance	2,649,354
Uncertain tax position	$ 50,000
Income taxes, description	Deferred tax assets related to foreign net operating loss carryforward, which begin to expire in 2028, in the amount of $973,900.

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	Jan. 04, 2021	Dec. 04, 2020	Oct. 30, 2020	Sep. 30, 2020	Sep. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Jan. 07, 2021	Sep. 01, 2020	Jul. 31, 2020	Jun. 17, 2019
Common stock, shares				14,685,932		13,258,707	10,589,746	101,705	2,667,349	800,000	6,520,099
Offering costs							$ 10,000,000
Recovery of up to approximately		$ 1,070,000
Installment amount	$ 2,062,500
Subsequent Event [Member]
Common stock, shares			5,000,000
Offering costs			$ 11,000,000

Revisions of Previously Issue_3

Revisions of Previously Issued Financial Statements (Details) - USD ($)	3 Months Ended				6 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Dec. 31, 2019	Mar. 31, 2020	Jun. 30, 2020	Jun. 30, 2019
Cost of revenues	$ 1,739,937	$ 1,396,219	$ 1,615,239	$ 1,379,701	$ 2,994,940	$ 4,391,159	$ 6,209,724	$ 4,633,844
Gross profit	1,974,067	1,674,327	1,690,964	1,813,189	3,504,153	5,178,480	6,363,552	6,189,273
Product development	1,758,826	874,787	623,501	610,902	1,234,403	2,109,190	3,206,310	5,565,097
Selling, general and administrative		5,678,242	4,883,172	3,601,714	8,484,886	14,163,128
Net loss	$ (4,750,691)	$ (4,744,129)	$ (3,763,695)	$ (2,326,332)	$ (6,090,027)	$ (10,834,156)	$ (16,384,104)	$ (12,403,215)
Net loss per share	$ (0.34)	$ (0.38)	$ (0.34)	$ (0.21)	$ (0.56)	$ (0.96)	$ (1.31)	$ (2.05)
As reported [Member]
Cost of revenues		$ 1,420,909	$ 1,638,840	$ 1,397,361	$ 3,036,201	$ 4,457,110
Gross profit		1,649,637	1,667,363	1,795,529	3,462,892	5,112,529
Product development		1,632,353	1,261,509	1,130,880	2,392,389	4,024,742
Selling, general and administrative		5,500,837	4,796,404	3,583,815	8,380,219	13,881,056
Net loss		$ (5,348,980)	$ (4,338,536)	$ (2,846,071)	$ (7,184,607)	$ (12,533,587)
Net loss per share		$ (0.43)	$ (0.40)	$ (0.26)	$ (0.66)	$ (1.11)
Adjustment [Member]
Cost of revenues		$ (24,690)	$ (23,601)	$ (17,660)	$ (41,261)	$ (65,951)
Gross profit		24,690	23,601	17,660	41,261	65,951
Product development		(757,566)	(638,008)	(519,978)	(1,157,986)	(1,915,552)
Selling, general and administrative		177,405	86,768	17,899	104,667	282,072
Net loss		$ 604,851	$ 574,841	$ 519,739	$ 1,094,580	$ 1,699,431